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This thesis describes the development of a combined label-free imaging and analytical strategy for intraoperative 
characterization of cancer lesions using the coherent anti-Stokes Raman scattering imaging (CARS) technique. A 
cell morphology-based analytical platform is developed to characterize CARS images and, hence, provide 
diagnostic information using disease-related pathology features. This strategy is validated for three different 
applications, including margin detection for radical prostatectomy, differential diagnosis oflung cancer, as well as 
detection and differentiation of breast cancer subtypes for in situ analysis of margin status during lumpectomy. As 
the major contribution of this thesis, the developed analytical strategy shows high accuracy and specificity for all 
three diseases and thus has introduced the CARS imaging technique into the field of human cancer diagnosis, 
which holds substantial potential for clinical ·translations. In addition, I have contributed a project aimed at 
miniaturizing the CARS imaging device into a microendoscope setup through a fiber-delivery strategy. A four-
wave-mixing (FWM) background signal, which is caused by simultaneous delivery of the two CARS-generating 
excitation laser beams, is initially identified. A polarization-based strategy is then introduced and tested for 
suppression of this FWM noise. The approach shows effective suppression of the FWM signal, both on 
microscopic and prototype endoscopic setups, indicating the potential of developing a novel microendoscope with 
a compatible size for clinical use. These positive results show promise for the development of an all-fiber-based, 
label-free imaging and analytical platform for minimally invasive detection and diagnosis of cancers during 
surgery or surgical-biopsy, thus improving surgical outcomes and reducing patients' suffering. 
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As a novel imaging technique, coherent anti-Stokes Raman Scattering (CARS) offers a unique feature of using 
intrinsic vibrations of chemical bonds to generate optical contrast (1 ). The resulting image possesses sub-
micrometer spatial resolution with video-rate acquisition speed (2). These valuable properties effectively 
eliminate the need for exogenous contrast agents to generate cellular images in real time, which is currently the 
most heavily studied approach for intraoperative evaluation of tumor margin status (3-6). More importantly, the 
elimination of these chemical contrast agents has resulted in more efficient patient care by shortening the FDA 
inspection process. In this chapter, the primary difficulties in intraoperative imaging of cancers and existing 
approaches with their pros and cons are reviewed, respectively. The working principle of CARS is then 
introduced. The technical advantages of this technique are speCifically highlighted. Finally, the potential 
usefulness and difficulties of translating the CARS technology into clinical applications are discussed. 
1.2. Challenges of Intraoperative Cancer Diagnosis 
Intraoperative and intrabiopsy cancer detection has been a major challenge for accurate determination of surgical 
margin and early diagnosis of cancers. Using common light microscopy, cancer and nerve tissues are not usually 
distinguishable from normal tissue structures, posing the main obstacle to the identification of different tissue 
types. As a result, definitive diagnosis is only accessible after tissue section and staining, a lengthy process that is 
always incompatible with the timeline of surgical interventions. Targeting this problem, substantial research 
effects have been allocated to provide real-time diagnostic capability (3, 7). Within all imaging modalities, optical 
methods are normally preferred, given their cellular resolution, a condition precedent to effective diagnostic 
judgment. This section reviews the major challenges in intraoperative and intrabiopsy imaging for three types of 
cancers. Existing methods and newly reported methods are introduced and their efficacies are also discussed. 
1.2.1. Margin Detection for Radical Prostatectomy 
In the United States, radical prostatectomy is the most common treatment utilized for men diagnosed with 
clinically localized prostate cancer (8). Cancer control, postoperative urinary and erectile function all determine 
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the efficacy of radical prostatectomy (9). While distinct factors may contribute to each, all are dependent, to some 
degree, on precise surgical techniques guided by intraoperative visualization (10). Nerve sparing (i.e., cavernous 
nerve (CN) sparing) anatomic prostatectomy is the most widely used procedure to preserve potency following 
extirpative surgery for prostate cancer (11). Dissection and preservation ofthe CN containing the neurovascular 
bundle depends on tactile sensation and visual cues during surgery. Anatomical landmarks are currently used as a 
basis for gauging locations of CNs ( 11 ), which are not visible, even with magnification; only the fibrofatty tissue 
likely containing the CNs is readily identifiable. Notably, the more proximal region ofthe CN in the area of the 
prostate pedicle is not identifiable; hence, injury to the CN in this location may occur more commonly than 
expected. In addition, it is quite possible that CN anatomy may vary from patient to patient, an issue that is 
currently difficult to assess. The lack of precise intraoperative nerve identification contributes to the overall 
challenge of minimizing nerve tissue damage during surgery and, hence, optimizing erectile function after surgery 
(12). 
As noted above, CN anatomy may vary from patient to patient. As such, the lack of precise intraoperative 
nerve identification contributes to the overall challenge of minimizing nerve tissue damage during surgery. On the 
other hand, positive surgical margins in the radical prostatectomy specimen imply that residual cancer may be 
present in the surgical bed (13). While not universally a poor prognostic sign, positive surgical margins can be a 
source of disease recurrence (13). During surgical removal of the prostate, it is not always possible to clearly 
distinguish prostate from non-prostate tissue and benign from malignant prostate tissue. Thus, an intraoperative 
tool for visualizing surgical margins would have significant clinical value and allow the surgeon to fine-tune 
margins of resection on the spot. Several intraoperative imaging modalities have been explored to provide direct 
visualization of prostate glandular architecture, periprostatic structures, and CNs in order to improve the rate of 
nerve preservation and post-operative potency. Fluorescent tracers, which are used to label CNs, have been 
imaged with a confocal fiber optic probe (Fig. 1.1) (14), but these techniques rely on fluorescent labeling agents 
that must be i) approved by FDA for human use, ii) applied in the correct anatomical compartment to facilitate 
imaging a given tissue, and iii) possess biocompatible properties. Label-free techniques are preferred to sidestep 
these hurdles. 
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Figure 1.1 Representative CN images of retrograde tracer selection trial produced using S-650-5.0 probe. Scale bar 
represents 50 um- taken from (14). 
Optical coherent tomography (OCT) (15) and two-photon autofluorescence microscopy (TPAM) (16), as 
label-free optical imaging strategies, have also been developed to resolve prostatic tissue structures. Based on 
OCT -generated images of various prostatic glandular structures, as shown in Figure 1.2, cancer lesions exhibit 
differently from normal glands. These OCT images can be further processed and segmented to indicate the nerve 
position (Fig. 1.3). Using NIR excitation, autofluorescence of the intrinsic fluorochromes (e.g. , reduced NADH, 
flavin adenine dinucleotide) can also provide the desired image contrast to identify prostate structures. Figure 1.4 
shows imaging results of prostate, nerve and fat structures using a two-photon excitation microscope, in which 
different prostate structures are well identified. Unfortunately, these techniques are usually hinpered by limited 
specificity, low spatial resolutions, and poor signal-to-noise ratio. Today, no real intraoperative imaging tool to 
visualize prostate surgical margins has been reported. 
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Figure 1.2 Left panel: OCT-generated images; physical dimensions are 1.0 mm (right to left) and 0.75 mm (top to 
bottom). Right panel: Images obtained after standard histopathological processing; physical dimensions are 1.0 mm 
(right to left) and 0.75 mm (top to bottom). (A) and (B) Fibromuscular stroma; (C) and (D)Benign Glandular Epithelium; 
(E) and (F) Fibroadipose Tissue; (G) and (H) Malignant Glandular Epithelium -adapted from (15). 
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Figure 1.3 (a) OCT-generated images of the rat cavernous nerve at different orientations (longitudinal, cross-sectional, 
and oblique): (a) and (b) longitudinal section; (c) and (d) cross section; (e) and (f) oblique section. (a), (c), and (e) 
Before; and (b), (d), and (f) after segmentation - taken from (17). 
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1.2.2. 
Figure 1.4 Two-photon microscopy images and the corresponding H&E stained sections of prostatic structures from a 
male Sprague-Dawley rat. (A) Prostate lobe at low magnification; (B) prostate acini at high magnification; (C) cavernous 
nerve at high magnification; the arrow shows the nerve sheath; (D) major pelvic ganglion; (E) fat at high magnification -
taken from (16). 
Detection of Early-Stage Lung Cancer 
Lung carcinoma is the most prevalent type of cancer in the world, and it is responsible for more deaths than other 
types of cancer (1 8). When symptoms occur, the disease has already progressed to an advanced stage, which is the 
major cause of the low survival rate (19, 20). Five-year survival rates after diagnosis are between 8% and 12% in 
Europe (20, 21 ) and less than 15% in North Americ~ ( 19). Early detection of lung cancer has attracted maj or 
research interest because it dramatically increases the survival rate (22, 23). Conventional detection strategies like 
sputum cytology (24-26) and X-ray (27-29) confront significant limitations because of their low detection rate 
(30, 31 ). As a result, several new technologies have been developed in the past few decades, and some of them 
have been utilized in clinical applications. 
It has been shown that Low-dose spiral CT (LDCT) is capable of detecting lung nodules at an earl ier 
stage than conventional chest X-ray (32, 33). Smaller nodules (2-3 mm) (24) can be detected with LDCT; 
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therefore, many lung cancers can be detected at Stage 1. However, this method is limited by its low specificity, 
leading to a large number of false positive readings and the necessity for follow-up evaluation in a significant 
number of tested patients (34). To further assess the pulmonary nodules (>7-8 mm) detected by CT, Positron 
Emission Tomography (PET) has been utilized (35, 36), particularly in characterizing the staging and possible 
metastasis of cancer (37, 38). However, this technique is still limited by its resolution (39) and susceptibility to 
respiratory motion (40). As a result, a tissue biopsy (normally fine-needle aspiration) is always included as a 
follow-up test after the detection of a nodule. The most prominent problem encountered by fine-needle aspiration 
is the difficulty of performing biopsy on nodules < 10 mm (34), making the diagnosis of small lung lesions a 
continuing difficulty. 
Clinical problems in early lung cancer detection have driven the development of bronchoscopies. While 
conventional white light bronchoscopy (WLB) is based on the detection of alterations in tissue surface structure, 
autofluorescence bronchoscopy aims at exploiting the spectral difference between normal and pre-/early 
cancerous tissues (41). Several companies (e.g., Xillix Technologies, Vancouver, Canada; Pentax, Japan) have 
been involved in the development and clinical trials of autofluorescence bronchoscopy for the detection of early 
bronchial cancers. The only approved clinical device (Xillix Technologies) takes advantage of the fact that 
cancerous lesions possess a higher level of backscattered red light than normal tissue when excited with a violet 
laser (Fig. 1.5). Size and specificity are the major limiting factors of this technique since smaller fiber optic 
instruments (<1 mm) are needed for diagnosis of peripheral lesions (34). 
Figure 1.5: Autofluorescence bronchoscopy imaging of a mild dysplasia - taken from (41 ). Combining violet excitation 
with backscattered red light enables highlighting of the lesion, which appears as a reddish area on a green backgroud. 
This specificity cannot be realized by using WLB or pure violet alone as the source of excitation. 
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As an emerging label-free technique, OCT formulates optical contrasts using the interference of two 
temporally incoherent iights, with a resolution of 2-10 urn and an imaging depth of 2-3 mm (42, 43). Micron-
level resolution allows in vivo investigation and screening for possible lung lesions using light reflected from 
within tissue to generate cross sectional images (44). In addition, OCT-based probes can be utilized with a 
conventional bronchoscope, thereby increasing biopsy yield and providing preliminary diagnostic results ( 45) 
(Fig. 1.6). Although micrometer resolution combined with label-free features has enabled OCT to achieve broad 
applications in the biomedical sciences, several limitations still hinder its accuracy. First, OCT generates contrast 
using changes of refraction indexes between tissue layers. Thus, while cancerous lesions can be differentiated 
from normal surrounding tissues ( 46), cancerous lesions without a clear boundary reduce the accuracy of OCT. 
Next, the micrometer resolution provided by OCT is able to resolve variations at the tissue level, but not cellular 
changes. As a result, the specificity of the system is limited, especially for tissue lesions with many variations in 
refraction indexes. Collectively, there is a great demand to develop a fast, accurate and cost-effective differential 
diagnostic tool for the early detection of lung cancer in order to increase accuracy, avoid unnecessary biopsy, and 
reduce patients' suffering. 
Figure 1.6: In vivo rabbit lung tumor imaging using OCT- taken from (45). (a)-(c) Reconstructed 3-D OCT images at 
different viewing angles. Cross sectional OCT images of noma! tissue (d) and tumors (e)(f) in rabbit lung. 
Corresponding H&E images of normal (g) and tumor lung tissues (h)(i). 
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1.2.3. Tumor Margin Detection for Lumpectomy 
Breast cancer is the second leading cause of cancer-related deaths in women (1 in 8 women; about 13%) and 
accounts for approximately one-third of all cancers diagnosed in women in the United States (47). To reduce 
cancer recurrence rate and progression, treatment decisions are absolutely critical. Lumpectomy and mastectomy 
are the principal surgical treatments for breast cancer. Compared to mastectomy, lumpectomy is increasingly 
preferred because it removes only the tumor and surrounding normal tissues. It has been shown that lumpectomy 
followed by radiation therapy, i.e., breast-conserving therapy (BCT), provides a survival rate similar to 
mastectomy (48-50), but significantly improved quality of life (51, 52), as long as the resected tissue specimens 
contain negative tumor margins, i.e., without cancer cells. The presence of a positive surgical margin has been 
associated with lower rates in patient survival (53, 54) since residual cancer cells tend to result in the recurrence 
near the site of the original tumor (55). Therefore, accurate delineation of tumor margins is one of the most 
important considerations for lumpectomy with regard to cancer recurrence (56-58). 
Currently, frozen section analysis (FSA) is the most widely used technique for intraoperative analysis of 
margins (59, 60). It starts with surgical removal of tissues that are visually perceived as cancerous and a circle of 
surrounding tissues. Next, these resected tissue specimens are immediately sent for frozen sectioning and 
detection of cancer cells. When enough tissues have been excised with negative margins, the surgeon will proceed 
with suturing the patient. In most cases, however, inadequate tissues have been removed, and positive margins 
require the surgeon to continue removing the remaining suspicious tissues, repeating the identification process 
until negative margin is identified. Each round of margin identification takes 15 to 20 minutes, and the surgical 
team waits for the response from the pathologist while the patient remains anesthetized. Clearly, the FSA 
procedure is both time-consuming and inconvenient. In addition, several factors affect its usefulness and 
accuracy. First, FSA is less preferred for small tumors because of its reduced accuracy for small lesions, as well 
as increased chance of leaving insufficient tissue samples for permanent section (61). Second, the accuracy of 
FSA is still limited by inherent artifacts caused by the take-out processing of tissues (61). Finally, FSA is time-
consuming and remains a costly solution. 
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Several alternate techniques have recently emerged for margin detection. Touch preparation cytology (or 
"touch prep" analysis) employs the fact that tumor cells possess loose cell connection and thus tend to stick to a 
clean glass surface compared to normal cells (62). Using hematoxylin and eosin (H&E) staining, touch prep is 
able to characterize tumor margin with easier preparation, better access to smaller lesions, lower cost and shorter 
analysis time (2 to 3 minutes) (62). However, low accuracy, as well as staining artifacts associated with drying 
and surface cautery, limit the applications of touch prep (61). Other alternatives, such as intraoperative ultrasound 
and intraoperative radiography, have also been explored for margin detection. Nevertheless, both techniques 
confront limited spatial resolutions and are therefore far less accurate than FSA (63). Raman spectroscopy is 
another modality that has been investigated for breast cancer imaging. It functions to identify disease lesions by 
capturing intrinsic chemical changes within tissues (64). Previous study has successfully demonstrated its 
usefulness in identifYing carcinomas by having a sensitivity of 94%, a specificity of 96% and an overall accuracy 
of 86% (Fig. 1.7) (65). However, this technique is limited by its long acquisition time (> 1 s/pixel) with high 
excitation power, preventing its applications from fast scanning of large surface areas with high spatial resolution 
(66). A recent study showed the use of multiplex CARS for interferometric imaging of breast cancer for 
identification of cancer margins (67). In this study, breast tissues were evaluated using their spectrum profile for 
construction of a digitized image for identification of tumor boundaries (Fig. 1.8). The strategy was based on the 
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Figure 1.7 Separation normal (stars}, fibrocystic change (diamonds), and DCIS (square) using calculations based on 














-5 0 5 10 
c2 x 1,ooo 
Figure 1.8 Classification of different regions of breast tissue using data calculated from multiplex CARS- taken from 
(67) . 
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1.3. Coherent Anti-stokes Raman Scattering Microscopy 
CARS microscopy was first reported in the 1980s by a group at the Navy Research Laboratory (68, 69). It 
captures intrinsic molecular vibrations to create optical contrast (70, 71). In the CARS process, a pump field (cop), 
a Stokes field (co.) and a probe field cop' (normally the same as <Op) interact with the samples through a four-wave 
mixing process (2). When the frequency difference, <Op- ro. (beating frequency), is in resonance with a molecular 
vibration, an enhanced signal at the anti-Stokes frequency, <088 = <Op - <Op + <Op, is generated in a direction 
determined by the phase-matching conditions (Fig. 1.9) (70). The major advantage of CARS is that the signal 
yield is much higher, typically several orders of magnitude, than the signal yield obtained through the 
spontaneous Raman scattering process (72). The intensity of CARS depends nonlinearly on two incident 
intensities: IcARS- I/•Is (73). As such, high peak powers are necessary, and CARS signals are tightly restricted to 
the focal plane, allowing a 3-D segmentation capability (74), similar to two-photon microscopy (75). In CARS 
excitation, the pump and Stokes fields coherently drive all resonant oscillators in the excitation volume at <Op - ro., 
generating a third-order polarization at the anti-Stokes frequency (76). The anti-Stokes intensity can be expressed 
as, 
Equation 1.1 
I OC: I (3) 12/2/ (sinc(Akz/2))2(70) AS X p s Ak/2 ' 
where z is the thickness of the sample, lp and I. are intensities of the pump and Stokes fields, Ak is the wavevector 
mismatch, defined as Ak = kas- (2kp - k.), and ki = 2TT/Ai. The sine function reaches maximum when Ak is close to 
zero, which is known as the phase-matching condition. Figure. 1.9 shows the phase-matching conditions for 
forward and epi-detected CARS signals. X(3) is known as the third order susceptibility which can be expressed as, 
Equation 1.2 
xC3) = lx~JI 2 + lx~3)(A)I 2 + 2x~Jnex~3)(A) (70), 
where x~3)(A) and x~J refer to the resonance and non-resonance terms, respectively. The third term is a mixture 
of the resonance and non-resonance terms, containing a real part from the vibrational response. The non-
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resonance signals are generated from the electronic response of the materials at the anti -Stokes frequency caused 
by a macroscopic polarization when the driving frequency, coP- co,, is away from the resonance peak. When the cop 
-co, is tuned to a particular molecular vibration frequency, the resonance signal is enhanced (74). This term is the 
dominant contributor to the formation of the CARS signal when probing at the resonance peak (Fig. 1.10 (a)) 
(70). The sum of the three terms results in a redshift of the spectral peak and a negative dip at the blue end (Fig. 
1.10 (b)) (77). 
a b c 
kp~as k p 
kp } kp 
l Ovib ks 
Figure 1.9: Phase-matching conditions of CARS- taken from (1) a) Generation of the CARS signal when roP - ro, matches the 
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Figure 1.10: Components of the CARS signal -taken from (1 ). a) Three components of CARS signal plotted against detuning. 
b) Total CARS signal by summing the three components. 
An important consideration for laser selection is the non-resonance background. The non-resonance 
background can be enhanced when the pump frequency is near the peak of the two-photon resonance of the 
material (73, 78). Under these conditions, near- infrared (NIR) pumping beams with wavelengths greater than 800 
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run avoid the two-photon enhancement of the non-resonance background. Moreover, NIR is considered highly 
attractive for imaging because this region of the spectrum is characterized by low absorption and high 
transmissivity by native chromophores in the tissue, such as proteins and other organic molecules (Fig. 1.11) (79). 
The use of an NIR source can therefore reduce two-photon-induced phototoxicity with increased imaging depth 
(74, 80, 81). In addition to the wavelength, the width of laser pulses is another consideration. Vibrational line 
width of a Raman peak is on the order of 10-20 cm- 1, while a common two-photon Ti::Sapphire laser has a pulse 
width around 100 fs, which is about 150 cm-1 in bandwidth. As a result, a femtosecond laser uses only a small 
portion of its energy to pump the narrow Raman line; however, it generates significant background signals 
without chemical specificity (1, 78). Figure 1.12 illustrates changes of the resonant and non-resonant parts of the 
CARS signal as a function of the pulse width. Hence, lasers with pulse widths of 1-3 ps are preferred to balance 
the signal intensity and the non-resonant background level (2, 78). 
Figure 1.11: Spectrum of absorption coefficient for water, haemoglobin (Hb02), melanin and haematoporphyrin derivative 
(HPD)- taken from (79). 
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Figure 1.12: Changes of CARS signal according to different temporal and spectral pulse widths - taken from (2). a) Changes 
of the resonant and non-resonant parts of the CARS signal and ratio as a function of the pulse width. b) CARS signal with 
regard to the pulse width. 
1.3.1. Biomedical Applications of CARS 
The capability of generating optical contrast from endogenous chemical structures has led to a rapid expansion of 
CARS microscopy for high-resolution imaging in various fields of biomedical research. CARS microscopy has 
been used to visualize various tissue structures, such as skin (74), lung (82) and kidney, as well as retina (1). 
Figure 1.13 illustrates tissue structures of a mouse ear specimen at a depth of 120-um with a CARS beating 
frequency tuned to the symmetric CH2 vibrational band, which is mostly rich in lipid droplets. The experiments 
employed the video-rate CARS imaging technique, allowing a rapid and 3-D reconstruction of the entire depth. In 
the field of cancer diagnosis, CARS has been utilized in the imaging of brain sections (Fig. 1.14) (2). Brain tissue 
is optimal for CARS imaging since it is lipid-dense. Using the CH2 stretching frequency, brain anatomy was 
revealed quite well at micron-level resolution. A large astrocytoma was also detected using the same resonance 
frequency because of its low lipid level. In addition to the CH2 vibrational frequency, other Raman bands have 
been used for CARS imaging. Figure 1.1 5 shows CARS images of a NIH3T3 cell in metaphase using the DNA 
23 
backbone vibrational band, which is the P02- symmetric stretching frequency at 1090 cm·1 (76). The 
chromosomes and organelles were very visible at different depths by their various levels of contrast 
Figure 1.13: In vivo images of a mouse skin specimen using CARS at a CH2 vibrational frequency. Changes of CARS signal 
according to different temporal and spectral pulse widths- taken from (2). Various tissue structures were observed at different 
depths, including a) Surface epithelium, b) Sebaceous glands, c) Adipocytes, and d) Subcutaneous fat. e) 3-D reconstructions 
of the imaging stack. 
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Figure 1.14: Brain tissue imaging using CARS -taken from (2). a) Mosaic images of a mouse brain coronal section using the 
lipid vibrational band. b) Zoom in on the image showing the white matter. C) H&E staining of the same region as shown in b). 
d) Mosaic image of a mouse brain specimen with an astrocytoma. e) Zoom in on image showing region of interest in d). 
1.3.2. 
(A)z+O J.Lm (B) z+l J.Lm 
Figure 1.15: Laser scanning images of a mitotic NIH3T3 cell at different depths using CARS - taken from (76). The 
pump and Stokes beams were tuned to 15393 and 12503 cm·1, respectively, resulting in a beating frequency of 1090 
cm·1. 
Advantages 
CARS microscopy is a powerful tool to visualize cellular structure within highly scattered tissue in vivo. It carries 
advantages over other imaging technologies because it formulates optical contrast without the necessity of 
exogenous contrast agents. Moreover, the chemical substrates in generating optical contrast can be manipulated 
by tuning the beating frequency, enabling a chemically-selective imaging strategy. These unique features have Jed 
to numerous biomedical applications in cell biology and neurosciences. 
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CARS microscopy offers many advantages, including, first, the generation of optical contrast using 
molecular vibrations, which are intrinsic features of the specimen. Since no natural or artificial fluorescent probes 
are required, CARS effectively avoids the toxicity, photobleaching and artifacts associated with the staining 
process. By tuning the beating frequency, CARS provides chemically-selective excitation of characteristic 
vibrational resonances, allowing imaging of particular chemical structures at will. Second, because of its coherent 
nature, CARS microscopy is several orders of magnitude more sensitive than spontaneous Raman microscopy. As 
a result, CARS requires a much lower average power for excitation ( ~0.1 m W, three orders of magnitude lower 
than that used in confocal Raman microscopy), minimizing the phototoxicity caused by the imaging process and 
enabling its long-term in vivo imaging applications. Third, as nonlinear microscopy, CARS offers 3-D sectioning 
capability since CARS excitation is restricted to the focal volume. Combined with a fast scanning platform, this · 
feature allows imaging of tissue and cell structures on a 3-D scale in real time. Finally, the optimum light sources 
for CARS are picosecond pulse lasers. Compared to the use of femtosecond lasers, this feature reduces the chance 
of two-photon-induced photodamage and increases the light penetration depth in thick tissue. 
1.4. Microendoscopy 
Although the imaging capabilities of CARS microscopy are promising, the practical implementation of this 
technique for clinical studies is still rather limited. A typical CARS platform involves a delicate research 
microscopic setup, which provides label-free imaging capabilities, but also limits access to the tissue surface. 
Therefore, to optimize this imaging technology for clinical diagnostic applications, it is necessary to develop a 
fiber-delivered probe, similar to those used in confocal fluorescence microscopy (83, 84) and optical coherence 
tomography (85), thus enabling minimally invasive examination through a process similar to tissue biopsy. 
Compared to advancements in endoscopy systems for two-photon excited fluorescence (TPEF) and 
second-harmonic generation (SHG) imaging (86, 87), the development of a CARS microendoscope system is still 
in its infancy. Different from TPEF and SHG, which involve only a single-pulse laser, CARS excitation requires 
two overlapped pulse trains, both temporally and spatially. Several challenges confront the design: 1) efficient 
propagation of two ultrafast pulse trains of different frequencies through fiber to the specimen; 2) suppression of 
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nonlinear effects, such as self-phase modulation (SPM) and stimulated Raman scattering (SRS), in the delivery 
fiber; and 3) efficient collection of the epi-CARS signal through fiber back to the detector. Thus far, single-mode 
fibers (SMF) (88) and single-mode photonic crystal fibers (PCF) (89) have been successfully demonstrated for 
use in the CARS imaging system. However, because of the single-mode requirement, the fiber core diameter is 
limited to -5f.U11 for step-index fibers and <l6f.Lm for PCF. Because ofthis relatively small-sized core, these fibers 
are susceptible to generating nonlinear effect, which will reshape the spectra of the laser pulses. In addition, the 
numerical aperture (NA) of these fibers is typically less than 0.1, resulting in unstable laser coupling as well as 
small coupling efficiencies(< 30%) (90). 
1.5. Clinical Potential 
The potential clinical impact of this technology is profound. First, the technology is non-destructive, when 
compared to conventional tissue biopsy, since it does not require removal of tissue specimens. Second, the 
technology provides in vivo imaging capabilities of tissue at high resolution (J..Lm scale), enabling translation of 
this microscopic imaging technique from the laboratory to the bedside by allowing the pathologist to observe 
tissue morphology, cell shape and density, and other pathologic features in vivo. By doing so, the technology not 
only provides a strategy to increase detection accuracy, but also allows on-site differential diagnosis of the lesion, 
especially for early diagnostic and intraoperative assessment applications. Third, the technology utilizes contrast 
generated from intrinsic chemical vibrations; therefore, it requires no exogenous contrast agents or tissue stains. 
The use of low-power NIR lasers further eliminates safety issues that often hinder clinical translation of other 
types of laser-based techniques. Successful completion of this project will generate a new cancer and nerve 
diagnostic technique that is capable of recognizing cancer and surrounding tissue features with chemically-
selective contrasts and submicron-level resolution and will aid in the identification of cancer structures and 
boundaries in vivo for surgical incision, both of which are important steps toward possibly reducing biopsy, 
shortening surgical time and increasing the survival rate of the patients. 
27 
1.6. Conclusions 
Clinical cancer diagnosis demands intraoperative imaging modalities that can be used to provide real-time 
guidance and analytical assistance for surgical incision or biopsy. Within commonly used imaging modalities, 
optical imaging approaches are attracting increasing attention because of their submicron imaging resolution to 
resolve disease-related cellular structures. Two common problems can impede the development of such a device 
for clinical use. First, many optical techniques, like fluorescence microscopy, require the introduction of 
exogenous agents to form . effective imaging contrast. This fact significantly reduces the chance of translating 
these approaches for clinical use as such contrast dyes are subject to the lengthy FDA approval process. Second, 
the developed system needs to have a compatible size for surgical intervention. This normally requires 
miniaturization of the imaging setup into a microendoscopy design with a diameter of the probe on the scale of a 
few millimeters. Such miniaturization usually poses significant technical challenges. 
Compared to other optical techniques, CARS provides label-free and submicron resolution modalities, 
both of which are critical properties for clinical translation. Taking advantage of these properties, this thesis 
successfully demonstrated the feasibility of using CARS technology to visualize and quantitatively characterize 
different types and subtypes of cancer tissues. A computerized diagnostic imaging system was developed to 
identify normal and cancerous structures using cellular features extracted from CARS images. This strategy is 
validated on three different cancer models, including prostate cancer, lung cancer and breast cancer. In addition, a 
raster-scan CARS microendoscope prototype was constructed for further in vivo imaging applications. In it, a 
polarization-based scheme was used to suppress the FWM background noise caused by the simultaneous 
transmission of the pump and Stokes beams in an optical fiber. The microendoscope prototype was shown to 
provide imaging resolutions at the micrometer level, potentially enabling identification of cancer structures in 
vivo. Therefore, further incorporation of the endoscopy system into the diagnostic strategy holds promise for 
future intraoperative diagnostic imaging of cancer tissues, thus improving the ability of surgeons to determine 
potential cancer lesions during surgical biopsy and characterize surgical margins during surgery. 
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2. Diagnostic Imaging of prostate glands and cavernous nerves using CARS 
L This chapture is adapted from the following publication: Liang Gao, Haijun Zhou, Yaliang Yang, Michael Thrall , Zhiyong Wang, 
Pengfei Luo, Kelvin Wong , Ganesh Palapattu, Stephen Wong, "Label-free imaging of prostate glands and cavernous nerves using 
coherent anti-Stokes Raman scattering microscopy", 20 II Mar 18;2( 4 ):915-26, Biomedical Optics Express. 
2. I performed a leading role in this project by designing the project, performing experiments, working on data interpretation and 
analysis, and drafting the manuscript. 
2.1. Introduction 
Prostate cancer remains a global health concern accounting for approximately 900,000 new cases annually 
worldwide (8). Radical prostatectomy is the most common treatment for men diagnosed with clinically localized 
prostate disease in the Western world. In this surgical procedure, the entire prostate is removed, and the bladder is 
reconnected to the urethra (91). The three main domains assessed to determine radical prostatectomy efficacy are 
cancer control and post-operative urinary and erectile function (9). While there are distinct factors that may 
contribute to each, all are dependent, to some degree, on surgical techniques (10). In an effort to improve 
intraoperative decision-making with respect to surgical plane dissection (i.e., surgical margins) and erectile 
function recovery (i.e., neurovascular bundle preservation), we sought to test the feasibility of utilizing CARS 
technology to visualize prostate and nerve tissues. 
Positive surgical margins on final pathology from a radical prostatectomy specimen imply that residual 
cancer may be present in the surgical bed. While not universally a poor prognostic sign, positive surgical margins 
can be a source of disease recurrence (13). During surgical removal of the prostate, it is not always possible to 
clearly distinguish prostate from non-prostate tissue and benign from malignant prostate tissue. Currently, 
surgeons must send samples of tissue for frozen section diagnosis to evaluate prostate margin, which takes about 
20 minutes (92). It is true that this technique is well-established and effective (93-95). At the same time, 
however, it may prolong surgery as a result of the time needed to process and interpret frozen section specimens, 
especially if multiple areas are sampled. Therefore, an intraoperative tool to visualize surgical margins in real-
time during surgery would have significant clinical value in that it would facilitate faster analysis of a greater 
number of areas of concern. 
Nerve-sparing anatomic prostatectomy is the most widely employed technique to preserve potency 
following extirpative surgery for prostate cancer (11). The preservation of post-operative erectile function 
currently depends on the exercise of tactile techniques and utilization of visual cues during surgery; however, 
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currently it is only possible to use anatomical landmarks to determine which nerve tissue should be the locus of 
the nerve-sparing procedure (11). CN fibers themselves are not visible; only the fibrofatty tissue encasing the 
nerve bundle is visible. This lack of precise intraoperative nerve identification, when coupled with various other 
factors, such as pre-operative erectile function and the intraoperative use of diathermy for hemostasis, contributes 
to the overall challenge of minimizing nerve tissue damage during surgery and optimizing erectile function after 
surgery (12). 
To meet this challenge, we investigated the feasibility of using CARS as an intraoperative imaging tool. 
In this study, human prostate and CN tissues are successfully imaged using a CARS microscope with cellular 
resolution. A single parameter, average cell neighbor distance based on CARS imaging, was presented as an 
effective parameter for characterization of normal and cancerous glandular structures. Therefore, our findings 
offer a high-resolution and label-free strategy for the detection of prostate and periprostatic tissue. CARS utilizes 
nonlinear excitation of intrinsic chemical bonds to form optical contrasts, allowing chemically selective imaging 
of targeted vibrational transitions in unstained samples, with sub-wavelength spatial resolution (1). Its highly 
directionally coherent nature generates strong CARS signals and offers high sensitivity and video-speed imaging 
rates (70, 74). Because of these advantages, the CARS imaging technique has been used to visualize various 
tissue structures, such as lung and kidney (1). In particular, a static body nerve was previously imaged by CARS 
(96). Since these results support the possibility of using CARS for the detection of prostate structures, especially 
prostate glands and CNs, it is entirely feasible that surgeons might be able to characterize prostate and 
periprostatic structures and thus better determine surgical margins and preserve CNs. 
2.2. 
2.2.1. 
Methods and Materials 
Optical imaging system 
The optical source system is composed of an optical parametric oscillator (OPO) and an Nd:YV04 laser. The 
Nd:YV04 laser delivers 7-ps, 76-MHz pulse trains at both 532 nm and 1,064 nm wavelengths. The Stokes wave is 
1,064 nm, while 532 nm is used to pump the OPO, which generates a tunable 5-ps output from 670 nm to 980 nm. 
The pump and Stokes beams are overlapped both temporally and spatially to generate CARS signals. A dichroic 
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mirror is used to separate CARS signals from excitation ps lasers. A bandpass filter (hq660/40m-2P, 25 mm 
diameter, Chroma Inc.) is placed before the detectors to collect CARS signals and block unwanted backgrounds. 
The microscopy system is modified from an FV300 confocal laser scanning microscope (Olympus, Japan), which 
is able to detect both backward (Epi-) and forward CARS signals. A 1.2-NA water immersion objective lens ( 60x, 
Olympus) is used with a resolution of0.4 J.tm and 0.9 1ft in the lateral and axial directions, respectively (97). The 
schematic of the microscopy setup is illustrated in Figure 2.1. 
2.2.2. Patient population and animal model 
Fresh human prostate tissues were obtained from 16 patients undergoing radical prostatectomy following Office 
of Human Subjects Research approval from The Methodist Hospital Research Institute (TMHRI). A transverse 
cut was made through the midportion of the prostate, and a small piece of sample (5 mm in each dimension) was 
taken in the peripheral zone for analysis. Human CN tissues were acquired from a non-nerve sparing 
prostatectomy patient for nerve imaging. 
2.2.3. Imaging strategies 
All samples were imaged ex vivo on a glass slide using the CARS microscope. An imaging chamber was created 
using an adhesive slide chamber. Prostate and nerve tissues were placed on a cover slip, which was reversely 
placed on the chamber to keep the samples from being pressed (Fig. 2.1). Z-stacks were chosen to better capture 
3-D structures of the tissue. All z-stacks were acquired at an X-Y dimension of 200 J.tm x 200 J.lll1 and a Z-scale of 
about 30 J.tm with 1 J.lm step size. The beating frequency was tuned to 2,845 em·' to probe the CARS signals 
originating from symmetric CH2 stretching bonds (1) and CARS signals were always detected in the epi-direction 
with a frame rate of 3.93 sin this study. The average power of each incident laser beam on the image plane was 
kept at less than 70 m W to protect the sample from photodamage. Two to four z-stacks were acquired for each 
specimen from different locations. In the normal cases, imaged locations were chosen to contain both glands and 
stroma to test the system's capability to identify the two typical types of structures within the prostate. In the 
cancer cases, imaged locations were chosen to contain predominantly glandular structures to test the classification 
system in distinguishing normal glands from cancer glands. After CARS imaging, the specimens were marked by 
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india blue to indicate the imaged side, sectioned perpendicularly to the microscopic axis, stained with H&E and 
finally examined by a surgical pathologist to determine the type of tissue as a standard control. Eleven of these 
samples were determined to be normal, while five of these samples were determined to be cancer. No discernable 
photodamage was detected on the H&E slides. 
2.2.4. 
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Figure 2.1 Schematic of the CARS microscopy system. The pump (816.7 nm) and Stokes (1,064 nm) beams are 
overlapped, both temporally and spatially, and delivered into a microscopy system. A dichroic mirror is used to separate 
CARS signals from excitation lasers for detection. D: PMT detector; OM: dichroic mirror; F: filter; L: lens; M: mirror 
Data Analysis 
Quantitative analysis was performed to separate cancer from non-cancer samples, supporting the potential of the 
system for clinical applications in determining surgical margins. To this end, a semi-automatic segmentation 
algorithm was developed to precisely delineate boundaries of cell nucleus (Fig. 2.2 (A)). The algorithm consists 
of one manual step and four automatic steps to obtain an accurate nuclear boundary, as shown in Figure 2.2 (B-F). 
1) A point within the cell nucleus is selected by the user. 2) An image patch in a square window with predefined 
size and a center at the selected point is cropped, and the target cell is contained in this square window. 3) A 
seeded watershed algorithm (98-1 00) is applied on the image patch to obtain a rough cell nucleus region. 4) Using 
a thresholding, or image segmentation process, the intensity of pixels within the square is measured, and another 
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rough nuclear region (binary image) is identified. Pixel intensity is defined as being within [m-1.75*~, 
m+1.75*~], where m and~ are the average intensity and standard deviation in a neighborhood of the center point. 
5) Finally, an ellipse is fitted to the refined cell nucleus region (overlapping the watershed and thresholding 
results), using the least square fitting criterion (101), to obtain a refined nuclear boundary. Following nuclear 
segmentation, five cellular features were calculated, including nuclear size, maximum, minimum and average 
neighbor distance of a cell in the Delaunay Triangulation graph (Fig. 2.2 (G)) (102) and variation of nuclear 
orientation between adjacent cells. Nuclear orientation is defined as an angle, 8 e [-90",90"] (arc degree), between 
the major axis of a cell nucleus (fitted by an ellipse) and the x-axis. The variation of nuclear orientation was then 
defined as the difference (absolute value) of this nuclear orientation value between one cell and its closest 
neighbor in the Delaunay Triangulation graph. In addition, a manual ellipse-fitting algorithm was developed to 
segment a small fraction of cell nuclei that cannot be well processed using the semi-automatic approach. In this 
algorithm, the user needs to select four points on the boundaries of the cell nucleus in order to generate an 
accurate cell fitting. Each z-stack was considered as an independent sample, and three images (at least 5 J.llD apart 
in depth from the first 20 J.llD of each z-stack) within each stack were used for analysis .. It took about 1-2 minutes 
for segmentation of all three images from each sample using this semi-automated segmentation strategy. Because 
of the diversity among different cells within each image, the measurement of each feature resulted in producing a 
unique distribution. To characterize these distributions, we then made use of the mean value and standard 
deviation of each distribution, leading to a total of 10 quantitative features (a tO-element vector) to represent each 
sample. A Principle Components Analysis (PCA) (103) was further performed to reduce the data dimensionality 
and reach immediate visualization of the data distribution. The basic idea ofPCA analysis is to analyze the data in 
a lower dimensional space. In brief, PCA maps data points from the raw coordinate system into a new coordinate 
system with lower dimensions (1 03). The first coordinate in the new coordinate space is chosen such that the 
projection of the raw data points on this coordinate has the maximum variance. As such, this coordinate will 
effective reflects the variability of raw data points. The second coordinate can then be determined in a similar way 
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Figure 2.2 Overview of the nuclear segmentation process and the resulting Delaunay Triangulation graph. (A) 
Snapshot of graphic user interface of CARS image analysis software; Red ellipses are the delineated cell boundaries. 
The green star represents one of the user-selected points, while the green square box indicates the image patch which 
will be processed; intermediate results: (B) targeted nucleus; (C) watershed segmentation algorithm; (D) local 
thresholding; (E) Ellipse fitting; (F) final result. (G) Delaunay Triangulation on the segmented image. 
Results and Discussion 
Imaging and Analytical Results 
Using CARS imaging, we were able to obtain images of both normal and cancerous prostate glands and CNs with 
sufficient resolution and level of contrast to allow identification of cellular structures and comparison to those 
from H&E stain. Figure 2.3 (A-E) illustrates representative CARS and H&E images of a normal prostate gland 
and its surrounding stroma. Normal glands show well-oriented epithelial structures with a predominance of 
relatively large glands organized into lobules, with the stroma consisting predominantly of mature fibrous tissue. 
These structures are closely correlated with the H&E picture from the same gland and stoma area (Fig. 2.3 (C) 
and (E)). The 3-D sectioning capability of the CARS technique was further utilized for revealing glandular 
epithelium structures at different depths. Figure 2.4 illustrates CARS images acquired from various imaging 
planes. The epithelial cells show polygonal structures on the surface (Fig. 2.4 (C)), and their nuclei are observed 
at a deeper plane (Fig. 2.4 (D)). CARS signals in these images mainly originate from lipid-rich cell and nuclear 
membrane structures. 
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Figure 2.3 Ex vivo images of human prostate gland and stroma structures using CARS and H&E stain. (A) A low 
magnification image shows the position of the imaged glandular (Yellow Square) and stroma (Red Square) areas. 
(8)/(C) high magnification CARS/H&E images of the prostate gland marked in (A). (D)/(E) high magnification 
CARS/H&E images of the stroma region marked in (A). 
Unlike normal glands, cancerous glands possessed crowded and more poorly oriented cellular structures 
with greater variation of nuclear size and shape. Figure 4 shows images of cancerous structures from three cancer 
patients with Gleason scores of 9, 8, and 9, respectively. Patient I (Fig. 2.5 (A-C)) has small malignant glands 
with distinct cell nucleoli apparent in the cell nuclei. Patient 2 (Fig. 2.5 (D-E)) has larger and more complex 
glands than patient I, but once again, nucleoli are apparent in some cells. Variation of nuclear size and shape is 
another distinct feature seen in patient 2. Some of the epithelial cells contain prominent secretory material in the 
cytoplasm, and this feature is also captured in the CARS image (Fig. 2.5 (F)). Patient 3 (Fig. 2.5 (G-I)) shows 
similar features in the imaged area, with significant nuclear pleomorphism and nucleoli seen. 
These distinctive cellular features are captured through the cell segmentation and feature extraction 
processes. Figure 2.6 (A-E) shows distributions of the five defined cellular features. The distribution patterns 
indicate maximum and average neighbor distance as promising features for separation of cancerous from normal 
glands. Quantitative analysis using PCA shows a clear separation of normal from cancer glands. Figure 2.6 (F) 
further illustrates separable 95% confident intervals for normal and cancer categories based on the Chi -square 
distribution (1 04) on the sample sets. Based on PCA results, we further investigated the coefficients of the top two 
principal components (Table 2.1). As expected, for the first principal component, means and standard deviations 
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of all neighbor distances (min, max and average) possess top-ranked coefficients, indicating their greater 
contribution to the separation process than the rest of the features. Therefore, we further studied the classification 
capability of the three neighbor distance features and found that the average distance has the best performance in 
separating cancer from normal tissues. Figure 2.6 (G) shows the box plot of normal and cancer groups using the 
standard deviation of average cell neighbor distance as a single feature. Student's /-test based on this plot shows a 
significant difference between the two groups (P<O.Ol , two tails), supporting the capability of this a single 
parameter from CARS images to characterize normal and cancerous glandular structures. 
Figure 2.4 CARS images of glandular epithelium structures at different depths and H&E images from a similar gland. 
(A) H&E image of a normal gland showing the appearance of glandular epithelial cells from different imaging planes. (B) 
Higher magnification image of the highlighted region in (A) showing different appearance of epithelial cells caused by 
variation in focal planes. Red and yellow arrows point to cells with and without a visible nucleus, respectively. CARS 
images from a similar gland show epithelial cells as polygons (C) at a shallow plane and with visible nuclei at a deeper 
plane (D). Cells indicated by the red and yellow arrows in (C) and (D) have structures comparable to those marked in 
(B). 
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Figure 2.5 CARS and H&E images of cancerous glands from three patients. (A)(B)(C) Low/ high magnification H&E 
images and a CARS image from the first patient. Red and yellow arrows point to an enlarged epithelial cell and a 
distinctive cell nucleolus, respectively. (D)(E)(F) Low/ high magnification H&E images and a CARS image from the 
same patient. Red and yellow arrows point to an enlarged epithelial cell containing prominent secretory material in the 
cytoplasm and a cancerous epithelial cell of relatively normal size. (G)(H)(I) Low/high H&E and CARS results from the 
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Figure 2.6 Feature extraction and PCA analysis. (A)-(E) Distribution of the five extracted features of the normal (blue) 
and cancer group (red); (F) Following PCA analysis, the spatial distribution of 23 normal sample sets and 17 cancer 
sample sets are plotted in the top two principal components space. The eclipses around the data points are 95% 
confidence intervals for normal (red) and cancer (blue) groups, showing a significant separation between the two 
groups. (G) Box plot of normal and cancer groups using a single-feature standard deviation of average cell neighbor 
distance. Blue bars represent samples' maximum and minimum, while red quadrangles indicate higher and lower 
quartiles of the samples. 
Table 2.1 : Coefficients of top two principal components in the 1 0-feature space. NS: Nuclear Size; NDV: Neighbor 
Distance Variation; Ave ND: Average Neighbor Distance; Max ND: Maximum Neighbor Distance; Min ND: Minimum 
Neighbor Distance. 
Features Mean Standard Deviation NS NDV Ave ND Max ND MinND NS NDV Ave ND Max ND MinND 
Principal Component I 0.15 -0.13 -0.42 -0.46 -0.37 0.06 O.DI -0.45 -0. 11 -0.47 
Princi~al Com~onent 2 -0.69 0.09 -0.15 -0 .09 -0.26 -0.59 0 .04 0.11 0.24 -0.06 
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For nerve imaging, our system was able to resolve CNs on a 3-D scale. Figure 2.7 shows a two-
dimensional projection of a CN using a 45-!lm deep z-stack and its corresponding H&E results. CARS signals 
mainly originated from lipid-rich myelin sheaths on the outer surface of the nerve fibers. As a result, individual 
nerve fibers were better illustrated in the cross-sectional images. 
2.3.2. 
120 pm .. ~ ' • ~-,. 
. 
Figure 2.7 Ex vivo images of a human cavernous nerve using CARS and the H&E stained structure of the same nerve. 
(A) Two-dimensional projection of 45 images from a z-stack with a step size of 1 iJm. YZ and XZ cross sections are 
presented in the right and bottom panels, which were constructed from the depth stack along the purple and yellow 
lines, respectively. (C) H&E image of the same nerve. 
Discussion 
In recent years, intraoperative imaging modalities have been widely explored to provide direct visualization of 
prostate and periprostatic structures to improve the rate of nerve preservation and post-operative potency. 
Fluorescent tracers, which are used to label CNs, have been successfully imaged with a confocal fiber optic probe 
(14), but they are limited by the safety and approval for human use. From a translational perspective, label-free 
techniques have an advantage in that they avoid the use of exogenous agents. For example, OCT (1 05) and two-
photon excited autofluorescence microscopy ( 16), as direct imaging strategies, have been able to resolve prostatic 
tissue structure. Unfortunately, these techniques are hindered by limi ted specificity. 
Aiming at these challenges, we have tested the feasibility of utilizing the CARS technique to image 
prostatic structures. Although there has been extensive previous work using CARS for tissue (1 , 74, 96) and cell 
imaging (I 06), preclinical experimental work is rare (I 07), and up to now, no data are available for prostate 
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applications. Our results demonstrate, for the first time, the capability of CARS to identify normal and cancerous 
prostate glandular structures as well as CNs. Since the human prostate has a poorly defined capsule, intraoperative 
characterization of the glandular structures may potentially allow better separation of prostate tissue from 
periprostatic structures, thus enabling better determination of the boundary of the prostate. Our novel cellular-
feature-based image analysis approach has broadened the clinical application of the CARS technique in 
diagnosing cancers and other diseases by quantifying the morphological features that can be identified by this 
technology, well utilizing its high resolution and label-free properties. Our study has also demonstrated high 
resolution imaging of CNs. Compared to adjacent muscle and prostatic tissues, CNs and adipose cells in nearby 
soft tissue possessed much brighter CARS emissions and thus required a lower gain for imaging. We believe that 
the CARS imaging morphology of nerve tissue is so strikingly distinctive that surgeons would be able to reliably 
identify nerves in most instances without having to call on pathologists. Therefore, this technology has the 
potential to decrease the rate of erectile function loss following radical prostatectomy procedures via improved 
neurovascular bundle identification. 
The current ex vivo study serves as proof-of-concept for future in vivo applications. Further 
miniaturization of our CARS platform into a microendoscope will be required for in vivo applications, along with 
thorough testing to ensure that the lasers will not cause unacceptable injury to probed tissue. Nevertheless, given 
the increasing efforts aimed at miniaturizing the CARS technique for fiber-based imaging (88, 89, 97), the 
miniaturization of this system is highly promising. In addition, the current ex vivo approach has significant value, 
even without the incorporation of an endoscope setup, as it could be readily used to examine surgical excisions 
during prostatectomy for evaluation of cancer margin and neurovascular bundles. The estimated time to analyze 
each tissue sample, including imaging and analysis, is under 5 minutes which is much shorter than the typical 20 
minute delay for frozen section analysis. Therefore, without frozen sectioning and the associated delays, our 
approach can significantly facilitate the surgical process and thus reduce surgical costs and patient suffering. 
For future application of this technology for radical prostatectomy, we envision surgeons having a probe 
that could be used, either manually or robotically, to provide real-time visualization of margins of concern. With 
high resolution, such probes would allow surgeons to pinpoint areas requiring further frozen section analysis to 
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rule out carcinoma. Differentiating between benign and malignant glands in prostate tissue is often challenging, 
even for experienced pathologists examining conventional histology (108), so it is not realistic to expect 
urologists to be able to make this distinction using CARS unaided. However, since cancerous glands appear to 
have distinctive cytologic and architectural features on CARS imaging, especially in higher grade tumors 
(Gleason pattern 4 or 5), it may be possible, with further study, to identify criteria that would enable pathologists 
to render real-time diagnoses of carcinoma using CARS images alone, at least in some instances, without frozen 
sectioning analysis. Additionally, following development and validation, future application of our technology may 
involve sending a live CARS image feed to a pathologist for real-time assessment intraoperatively. Further 
improvement of algorithmic image-analysis tools based on current results will be another strategy to facilitate the 
integration of the CARS imaging system with current surgical approaches as computerized decision making 
systems. As a result, this CARS-based approach could potentially improve and fundamentally change the practice 
of nerve-sparing approaches to radical prostatectomy by offering a cost-effective, label-free strategy for 
characterization of surgical margins and periprostatic structures. 
2.4. Conclusion 
In this chapter, we demonstrated, for the ftrst time, the feasibility of using the CARS imaging technique to detect 
prostate glands and CNs with cellular resolution using intrinsic molecular contrast. The current approach is 
readily compatible with radical prostatectomy for ex vivo examination of surgical excisions for facilitated 
evaluation. Further improvement in the CARS technology holds promise for the intraoperative identification of 
prostatic and periprostatic structures, thereby potentially improving the ability of surgeons to determine prostate 
margin status as well as maximally preserve CNs in real time. 
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3. CARS for Differential Diagnosis of Human Lung Cancer 
I. This chapture is adapted from the following publications: 
a. Liang Gao, Fuhai Li, Michael Thrall, Yaliang Yang, Jiong Xing, Ahmad Hammoudia, Hong Zhao, Yehia Massoud, Philip Cagle, Kelvin 
Wong, Hong Zhao, Stephen Wong, "On-the-Spot Lung Cancer Differential Diagnosis by Label-free, Molecular Vibrational Imaging and 
Knowledge-based Classification", Vol. 16, No. 9, 2011, Journal of Biomedical Optics (selected for publication in Virtual Journal of 
Biological Physics Research). 
b. Liang Gao, Yaliang Yang, Jiong Xing, Michael Thrall, Zhiyong Wang, Pengfei Luo, Kelvin Wong, Hong Zhao, Stephen Wong, 
"Diagnosing lung cancer using coherent anti-Stokes Raman scattering microscopy", Proceeding ofSPIE, Vol. 7890, 20 II 
2. I performed a leading role in this project by designing the project, performing experiments, working on data interpretation and 
·analysis, and drafting the manuscript. I received significant help on the data analysis part. My contribution to that part was designing 
the analytical strategy while contributing to the modifiCation of program codes written by my collaborator. 
3.1. Introduction 
Lung cancer among both sexes is the primary cause of cancer deaths in the United States with 222,500 new cases 
and 157,300 lung cancer related deaths projected for 2010 (109). Worldwide, the five-year survival for lung 
cancer patients ranges from 6 to 14% for men and 7 to 18% for women, a very dismal prognosis that has not 
substantially changed in decades (18, 110). Even though early detection of lung cancer has attracted major 
research interest (22, 23), less than 1% of patients with early-stage lung cancer can be diagnosed (34). Pulmonary 
examination using computed tomography (CT) and magnetic resonance imaging (MRI) does highlight 
abnormalities. However, these technologies are not often able to distinguish lung carcinoma from benign lesions, 
such as organizing pneumonia. As a result, a tissue biopsy is still needed as a follow-up test after the detection of 
a nodule. 
Traditional open lung biopsy requires general anesthesia and an invasive surgical procedure. CT-guided 
percutaneous core biopsy or fine-needle aspiration reduces the amount of tissue taken and complications, though 
pneumothorax and hemorrhage remain significant concerns. In addition, because of the respiratory motion of 
patients, it remains difficult to obtain samples precisely at the site of small lesions (34). Therefore, some patients 
will need to undergo re-biopsy, resulting in increased costs and delay in diagnosis and treatment. Given the risks 
and cost of lung biopsy, it would be beneficial to develop techniques that limit damage to lung tissue, diagnose 
lung cancer in real time, and provide equal or greater diagnostic yield than existing biopsy methods. 
Consequently, several new technologies have been developed in the past few decades. 
Bronchoscopy, for example, has been widely explored for early lung cancer detection. While 
conventional white light bronchoscopy is based on the detection of alterations in tissue surface structure, 
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autofluorescence bronchoscopy aims at exploiting the spectral difference between normal and pre-/early 
cancerous tissues (41, 111). Size and specificity are the major limiting factors ofthis technique since a small fiber 
optic probe (<1 mm) is needed for diagnosis of peripheral lesions (34, 112). OCT is another imaging modality 
that is compatible with the design of a conventional bronchoscope (45). Micron-level resolution allows in vivo 
investigation and screening for possible lung lesions using light reflected from within tissue to generate cross-
sectional images (44). However, OCT only generates contrast using changes of refraction indexes between tissue 
layers, limiting its specificity and accuracy. 
In view of the collective limitations of the techniques discussed above, there is a great demand to develop a real-
time imaging tool to increase the biopsy yield and potentially provide diagnostic information to facilitate 
definitive treatment. This tool would need to offer cellular resolution, fast imaging rate and molecular specificity, 
but without the use of exogenous contrast agents or probes, such as fluorescent dyes, since few of these agents or 
probes have been approved for human use. Current techniques cannot meet one or more of these criteria and thus 
fall short of their full potential as effective diagnostic tools. 
CARS imaging technique (113), on the other hand, satisfies all the above parameters and therefore holds 
great promise for this diagnostic application. It captures intrinsic biomolecular vibrations to create optical contrast 
with submicron level spatial resolution, as well as video-speed imaging rate (1). The major advantage of CARS is 
that the signal yield is much higher, typically several orders of magnitude, than the signal yield obtained through 
the conventional spontaneous Raman scattering process (74). Because of these advantages, CARS microscopy has 
been used to visualize various tissue structures, such as skin (74), lung, and kidney (1). In the field of cancer 
imaging, a recent study showed the use of multiplex CARS for interferometric imaging of breast cancer for 
identification of cancer boundaries (67). However, differential diagnosis of cancer using CARS microscopy has, 
to the best of our knowledge, not been attempted. Currently, in order to accurately delineate the type oflesions for 
definitive treatment, pathologists routinely stain lung biopsy tissue to examine changes in such cellular and 
histologic features as cell size, cell-cell distance, and formation of fibrous structures (114). However, while this 
method is subject to inter-observer variations, the CARS technique already provides high-resolution images 
which can clearly detect these features, without tissue staining with exogenous agents. Therefore, we hypothesize 
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that the development of a label-free imaging and pattern recognition method whereby such images could be used 
as a basis for the quantitative classification of these cellular features in a way that would lead to a differential 
analysis of lung cancer. This hypothesis was supported by our recent publication (115) that studied the 
differentiation of cancer from normal prostatic glands in order to aid surgical decision on margin status using 
calculated cellular features from CARS images. One of the cellular parameters (average cell neighbor distance) 
was determined to be a good candidate for cancer differentiation using PCA. Inspired by the research findings in 
(115), this study aims to perform in-depth classification analysis and calculate the accuracy of the classifier using 
a leave-one-out training and testing design. In another words, potential cellular parameters are not only selected 
but also tested for constructing a classifier to separate different types of lung lesions. The current study will 
provide comprehensive and robust results with regards to cancer differential diagnosis using the CARS-based 
technology ex vivo and will bring the proposed approach of coupling label-free imaging with pattern recognition 
for cancer diagnosis closer to clinical applications. Accordingly, the established pathological workup and 
diagnostic features were used as prior knowledge for establishment of a knowledge-based CARS classification 
module using a machine learning approach. This module was integrated with the CARS microscopy system to 
provide real-time differential diagnosis oflung lesions using quantitative measurements taken from the visualized 
cellular features and patterns. To the best of our knowledge, this is the first label-free and knowledge-based 




Methods and Materials 
Tissue Preparation and Imaging 
Lung tissues were obtained from patients undergoing surgical biopsy and surgery at The Methodist Hospital 
(TMH), Houston, TX. Upon removal, the samples were snap-frozen in liquid nitrogen for storage. They were 
passively thawed at room temperature and kept moist with phosphate buffered saline before imaging. A total of 
75 cases were acquired from TMH, including 19 normal cases, 20 adenocarcinoma cases, 25 squamous cell 
carcinoma cases, 3 small cell carcinoma cases, 6 organizing pneumonia cases and 2 interstitial fibrosis cases. 
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Seventeen additional frozen samples were purchased from the Cooperative Human Tissue Network, including 2 
small cell carcinoma cases and 15 interstitial fibrosis cases. Because resection is usually not clinically indicated, 
small cell carcinoma cases are only infrequently made available for scientific research, resulting in a lower 
number ofthis type oflesion. Tissue samples were imaged on a glass slide using the CARS microscope, ex vivo. 
The schematic of the microscope setup is illustrated in Chapter 2 (Fig. 2.1). Three to four sampling points 
were imaged for each specimen, and a total of 338 sampling points were examined. At each sampling point, three 
images were acquired from different imaging depths, resulting in a total of 1,014 images. The beating frequency 
was tuned to 2,845 em·' to probe the CARS signals that originated from symmetric CH2 stretching bonds. After 
CARS imaging, all specimens were marked to indicate the sampled locations, sectioned through marked 
locations, and finally stained with H&E. Bright-field images of these H&E slides were captured and examined to 
determine the type of lesion as a standard control. 
3.2.2. Data Analysis 
While the front-end CARS microscopy system acquires the initial images, the back-end knowledge-based 
classification module, consisting of nuclei segmentation, feature extraction, and classification analysis functions, 
is built on identifying cellular and fibril structural features in order to separate different kinds of lesions. The goal 
is to classify tissue samples into individual subtypes through a three-level process (Fig. 3.1), which simulates 
clinical diagnostic workup. In the first level, a lesion is identified as cancerous or non-cancerous (normal and 
benign). The cancerous group includes all three subtypes of lung cancers (adenocarcinotpa, squamous cell 
carcinoma, and small cell carcinoma) while the benign group includes organizing pneumonia and interstitial 
fibrosis. A total of 145 cell/fibril features are calculated directly without segmentation from the CARS images. 
The same features were further used for the separation of normal and benign cases in part of the second level. In a 
clinical setting, the practitioner must initially characterize a lung nodule lesion as normal, cancerous, or benign, 
and these two steps mimic this diagnostic process. The other part of the second level and the entire third level of 
our scheme focus on separation of subtypes of cancers, which includes segmentation of the cell nucleus and 
measurement of pathologically related features; Specifically, after segmentation, we use parameters, such as cell 
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volume, nuclear size, and cell-cell distance, to measure a total of 35 features and thereby separate cancer 
subtypes. 
Figure 3.1: Overview of the three-step differential process 
3.2.3. Separation of Cancerous, Benign and Normal Samples 
Fibril and cell structures can be used to separate cancerous from benign and normal samples because changes in 
these structures are closely related to different kinds of lung lesions, including cancer, pneumonia, and interstitial 
fibrosis (114). Therefore, in the first step of the differential design, we extracted a set of 145 informative features 
and built a classifier to characterize fibril and cell features in order to separate fibril-dominant normal and benign 
lesions from cell-dominant cancerous lesions. Although both normal and benign lesions are fibril-dominant, they 
appear differently with regards to the orientation and/or distortion of the fibrils in our CARS images (Fig. 3.2). 
The same set of quantitative features was further used to train a classifier for separation of normal tissue from 
benign lesions. This set of 145 features consists of three feature categories widely used in image-based retrieval 
and pattern recognition: 85 wavelet features, 13 Haralick Co-occurrence features (116, 117), and 47 Zemike 
Moment features (the first and the second out of 49 Zemike moment features are discarded due to they have the 
same values for all the images) (118). The wavelet features come from two important wavelet techniques: 70 
Gabor wavelet features (119) and 15 Cohen- Daubechies- Feauveau wavelet (CDF9/7) features (120). 
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3.2.4. 
Figure 3.2: Ex vivo images of human lung lesions. CARS and H&E images of (A) (B) normal lung (C) (D) squamous 
cell carcinoma (E) (F) adenocarcinoma (G) (H) small cell carcinoma {I) (J) organizing pneumonia and (K) (L) organizing 
pneumonia derived from the same patient, respectively. Scale bars: 50 IJm. 
Separation of Subtypes of Cancers 
3.2.4.1. Segmentation of Cancer Cells 
In contrast with non-cancerous groups, cancerous samples show a high density of cancer cells whose nuclei can 
be identified by CARS because of their low CH2 level (Fig. 3.2). Moreover, cellular details evident in CARS 
images enable us to measure additional morphological characteristics utilized by pathologists to identify different 
subtypes of cancer, including nuclear size, ceiJ volume, and cell-ceiJ distance, which correspond to such 
pathological criteria as pleomorphism and nucleus-to-cytoplasm (N/C) ratio. To perform measurements of these 
features, segmentation of ceiJ nucleus is an essential step. Since CARS images bear a low level of contrast and a 
high level of noise, it is often not compatible with fully automatic detection approaches in identifying nuclear 
boundaries with a high degree of accuracy. As a result, the same semi-automatic segmentation algorithm, which is 
used in Chapture 2, was employed to serve this purpose. This strategy was fast enough to obtain segmentation 
results within minutes, was employed to precisely delineate the boundaries of ceiJ nuclei (Fig. 2.2). The algorithm 
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consists of one manual step and four automatic steps to obtain an accurate nuclear boundary, as described in 
(115). In addition, a manual ellipse fitting algorithm was developed to segment a rare fraction of cell nuclei that 
could not be well processed using the semi-automatic approach. In this algorithm, the user needs to select four 
points on the boundaries of the cell nucleus in order to generate accurate cell fitting. 
3.2.4.2. Validation of cell nuclei segmentation 
To validate the semi-automated segmentation algorithm, one hundred cells were randomly selected from 10 
CARS images for each of three cancer subtypes. The semi-automated segmentation results were compared with 








where S; is the ground truth of the i-th cell manually measured and s'; is the semi-automated 
segmentation result measured by the software. TP, FP and FN are true positive, false positive and false negative, 
respectively, and are defined as follows: 
Equation 3.2 
FP=S'; -(s;ns';) TP=S; ns·; FN=Si -(Si nsi) 
' 
Figure 3.3 shows validation of the segmentation results in terms of precision, recall and fscore. All three 
indexes are close to, or above, 90% for the tested cell nuclei, validating the accuracy of the segmentation method. 
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Figure 3.3: Validation of cell nuclei segmentation 
3.2.4.3. Design of Informative Cellular Features 
Following nuclear segmentation, seven cellular features were designed and calculated to capture cellular 
signatures of cancer subtypes. These features include size of the nucleus, length of major and minor axes of the 
nucleus, area ofVoronoi Tessellations (121-123) (Fig. 3.4 (A)), as well as the maximum, minimum and average 
neighbor distance of a cell based on the Delaunay Triangulation graph (1 02) (Fig. 3.4 (B)). These features 
describe both the attributes of individual cells and their relative spatial distribution. However, because of the 
diversity among different cells within each CARS image, the measurement of each feature resulted in producing a 
unique distribution (115). Therefore, we made use of five additional parameters to describe each distribution type 
(i.e., mean value, standard deviation, skewness, kurtosis, and entropy), resulting in a grand total of 35 features. 
The mathematical definitions of skewness y1(x), kurtosis y2(x), and entropy H(x) are as follows: 
Equation 3.3 
r, (x )= r[(x - ,u)/af p(x)dx 
' 
r2(x ) = r (x - ,U)4 p(x )dx/[ r (x - ,u)2 p(x )dx r - 3 
and, 
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H(x) =-r log2(p(x))p(x)dx 
where xis a random variable whose observations are within [a, b], p(x) is the probability density function 
of x, and Jl and a denote the mean and standard deviation of x, respectively. 
Figure 3.4: Representative results of (A) Voronoi Tessellation and (B) Delaunay Triangulation on a small cell carcinoma 
image. 
3.2.5. Differential Diagnostic Analysis 
3.2.5.1. Partial Least Square Regression (PLSR) Analysis 
PLSR analysis was utilized to reduce the dimensional framework for immediate visualization of the spatial 
distributions of different types of tissue. This analysis aims to predict dependent variables, Y, from independent 
variables, X, by borrowing ideas from PCA (124). In other words, PLSR aims to use principal components of X 
to predict Y . Different from PCA analysis, in which the chosen principal components may not be related to Y , 
PLSR utilizes components that can explain the covariance between X and Y ( 124, 125), resulting in a better 
separation of individual subtypes when plotted for visualization. In brief, it employs two vectors, c and w, to 
maximize the following correlation: 
Equation 3.4 
[cov(u,t)f = [cov(Yc,Xw)f 
where u, tare the score vectors for Y and X, respectively. To achieve this goal, the nonlinear iterative partial 
least squares (NIPALS) algorithm is used (125), and a clear description of this implementation is discussed in 
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(124). It is an iterative process, and once the i-th score vectors u1 and t 1 are obtained, the process is applied to the 
residual matrixes Y1 and X1 to get the next set of u1+1 and t 1+1 • 
Equation 3.5 
Y; = Y;_1 - u1q; and X1 = XH - t1p; 
' 
Equation 3.6 
XT17{· p- 1- I 
where 1 - t/ t; 
' 
yr~x q - 1- I ;- T 
and U; U;. 
To visualize the spatial distribution of different types of lung lesions, we employed the top three score 
vectors of all the samples such that each sample was represented by this three-dimensional vector. All the samples 
were then plotted in the 3D space with the three selected vectors as axis, as shown in Figures 3 and 4. To enhance 
visualization, samples from each subgroup were enclosed with a 3D ellipsoid obtained using the minimum 
volume enclosing ellipsoid (MVEE) strategy (126). 
In the PLSR analysis, the variable importance in projection (VIP) index, which ranks the importance of 
variables for separating different classes, is calculated as follows (127): 
where K is the number of selected components (in our study, K = 3) and b" = t~ u.t . 
3.2.5.2. Support Vector Machine Based Recursive Feature Elimination (SVM-RFE) 
Support vector machine (SVM) is one of the commonly used classifiers. It focuses on maximizing the margin 
between two classes ( 128). Mathematically, a classification problem can be described as y = wl:k + b, where w is a 
weight vector, and b is a bias value. To train the classifier, SVM minimizes the following function over a 1 : 
Equation 3.8 
~ L.y1y1a1a1 ( x1x1 + A.t5!i)- La1 , subject to, 1 ~ a1 ~ C, and ~a1y1 = 0 
!J J J 
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Feature selection techniques are widely used in machine learning and classification analysis to reduce the 
risk of over-fitting caused by the use of a large number of features (128-130). Recursive feature elimination (RFE) 
is a popular feature selection method (130). SVM-RFE was generated by integrating the SVM classifier with the 
RFE method (130, 131). The idea of SVM-RFE is to recursively eliminate features based on the weight 
magnitude of a SVM classifier. Its implementation is straightforward and described in (130). In brief, for a given 
set of features f=(J;,J;, ... ,fm), it trains a SVM classifier to calculate the weight vector w. Then it eliminates 
the feature with the smallest weight, llw;ll2 , which reflects its potential contribution to the classification. After one 
feature is eliminated, the remaining feature subset is used again to train the classifier for the elimination of 
another feature. This process repeats itself to eliminate features until one feature remains. 
3.2.5.3. Diagnostic Calculations 
Having extracted two sets of quantitative features (145/35), we could finally perform differential diagnostic 
analysis. There are two classification algorithms used in this paper: PLSR (124, 125) and SVM-RFE (128-130). 
Specifically, PLSR analysis (125) provides a global view of the distribution of different types of lesions by 
mapping the original feature space into a new space in which the predicted and investigated variables are 
maximally correlated (124, 125). This results in an optimal visual separation of samples in a 3D space. Since the 
main advantage of PLSR lies in regression analysis, rather than classification analysis ( 125), we further employed 
the SVM-RFE approach (128-130) for differential analysis and the investigation on changes of classification 
accuracy with different number of features through a feature selection process in order to overcome possible 
overfitting problems. 
To validate the classification algorithm, a leave-one (patient)-out cross-validation analysis was used. In 
this step, experimental data from one of the patients were used for testing, while the remaining patient data were 
used to train the SVM classifier. The training and testing datasets were randomly selected and repeated 100 times 
to test the accuracies of classification. Since three images were acquired for each sampling point, the voting 
strategy, which determines the patient's lesion type according to the classification results of the majority of the 




Results and Discussion 
Label-free Molecular VIbrational Imaging of Different Types of Lung Lesions 
Figure 3.2 shows our representative CARS images and corresponding H&E results of normal, cancer and non-
cancer lesions. Tissue structures were clearly identified on the cellular level. The normal lung is predominantly 
composed of well-organized fibrous structures, consisting of the bronchi and supporting matrix for alveoli (Fig. 
3.2 (A) and (B)). Cancer regions showed much denser cellularity compared with normal regions, and the size and 
configuration of the cells corresponded with these parameters, as shown by H&E stain (Fig. 3.2 (C)-(H)). 
Commonly used pathological features were also identified for individual subtypes of cancers, including large 
polygonal malignant cells in sheets with abundant dense cytoplasm for squamous cell carcinoma, nested large 
round cells with abundant inhomogeneous cytoplasm for adenocarcinoma, and round or oval cells with minimal 
cytoplasm (high N/C ratio) and nuclear molding for small cell carcinoma. Meanwhile, organizing pneumonia and 
interstitial fibrosis (Fig. 3.2 (1)-(L)), two types of non-cancerous lesions served as controls, showed dense fibrous 
structures with distortion ofthe normal lung architecture similar to those shown by the corresponding H&E stains. 
The lack of cellularity in the images of benign cases, as compared to both normal and cancerous cases, could be 
explained by the predominant signals from the fibrous tissue as well as extracellular matrix. 
3.3.2. Differential Diagnostic Analysis 
3.3.2.1. Separation of Cancer from Non-cancer 
As indicated in Figure 3.2, normal and benign tissues possess clear fibrous structures, while cancer tissues possess 
high-density cellular features without obvious fibril formation. Using the 145 features, these fibrous and cellular 
signatures were numerically characterized, enabling the separation of normal, cancer and benign cases. Figure 3.5 
(A) illustrates the 3D spatial distribution of normal, benign and cancer samples using PLSR analysis, in which all 
three groups are visually separated. The SVM-RFE approach was further employed to optimize classification 
accuracy and identify optimal feature combinations. Figure 3.5 (B) shows the classification accuracy when 
different feature combinations (using 1 up to all 145 features) are used to separate cancer from non-cancer cases. 
For separation of cancer subtypes, the results indicate that the accuracy reaches a stable peak level with 11 to 16 
features. Figure 3.6 (A) illustrates the classification accuracy with an optimal 11-feature set. Over 92% and 91% 
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of samples from cancer and non-cancer tissues are correctly classified. Again, Haralick Co-occurrence texture 
features show their importance in this separation step because all members (sum variance, sum of squares, 
contrast, difference variance and sum average) from the top 5-feature subset after SVM-RFE belong to this 
category, which again demonstrates its superior ability to describe fibrils and cell structures for building a 
classifier. 
Although all cancer samples can be visually well separated from non-cancer samples using their 
distinctive cellular features, the developed semi-automated strategy still shows difficulties in precisely extracting 
fibrous and cellular features to reach 100% accuracy. In our 145 features-based classification strategy, membranes 
around cell nuclei in cancer lesions were sometimes considered as fibers, while the dark holes between the fibers 
in the non-cancer cases were confused with cell nuclei. Still, as an ancillary tool for clinical diagnosis, current 
accuracies are good enough to produce reliable results. 
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Figure 3.5: Separation of normal, begin and cancer lesions using PLSR and SVM-RFE based feature selection. (a) 
Spatial distributions each group using PLSR analysis. The top three-scored vectors were first calculated through PLSR 
analysis on all lung samples such that each sample could be represented by this three-dimensional vector with a scale 
normalized from 0 to 1. All lung samples were then plotted in a 3D space of these three vectors for separation. To 
enhance visualization, three ellipsoids were further fitted to the three subgroups with the ellipsoids projected onto the 
first and second components (in the PLSR analysis). (b) and (c) Classification analyses through SVM-RFE of cancer 
versus noncancer samples and normal versus benign samples on the 145 feature set. 
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Figure 3.6: Classification accuracies of separating (a) cancers from noncancers using the top 11 features through 
SVM-RFE on the 145 feature set; (b) benign from normal cases using the top 110 features through SVM-RFE on the 
145 feature set. (c) small cell from nonsmall cell carcinoma using the top 1 feature obtained through SVM-RFE on the 
35 feature set. (d) Squamous cell carcinoma from adenocarcinoma using the top 25 features obtained through SVM-
RFE on the 35 feature set. 
3.3.2.2. Separation of Normal from Benign Tissues 
As shown in Figure 3.2, normal tissues possess moderate fibrous structures with clear orientation while benign 
cases have predominant fibrous structures with distortions. Figure 3.5 (C) shows classification accuracies using 
different subsets of feature combinations through a SVM-RFE feature selection process, in which the accuracy 
reaches a stable level with the use of around 110 features. Using a 110-feature subset, over 92% and 89% 
accuracies were achieved for benign and normal samples, respectively (Figure 3.6 (B)). To account for the 
percentage shortfall, we know that pathological changes in benign lesions are such that certain sampled locations 
possessed a lower level of abnormality, thus showing tissue structures similar to those of normal cases. However, 
in a real differential diagnostic process, current results are more than sufficient to achieve the main goal: 
delineating benign samples (over 92%) from the normal. 
3.3.2.3. Separation of Subtypes of Lung Cancers 
Using the semi-automatic segmentation algorithm, we were able to delineate boundaries of an individual cell 
nucleus, enabling the measurements of 35 numerical features (Fig. 3.7). The spatial distribution of the three 
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subtypes of cancers is illustrated in Figure 3.8 (A). All small cell cancer cases are well separated from non-small 
cell subtypes, while the latters overlap in a certain extent in distribution. SVM-RFE analysis showed that the 
classification accuracy between small cell and non-small cell cancers reaches 1 00%, even with only one feature 
(Fig. 3.6 (C)), i.e., Voronoi Tessellation. 
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Figure 3.7: Distributions of the seven features of three cancer subgroups: small cell carcinoma (red), adenocarcinoma 
(green), and squamous cell carcinoma (blue). We randomly chose 5000 cells from each subtype and investigated the 
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Figure 3.8: Separation of cancer subtypes using PLSR and SVM-RFE based feature selection. (a) Spatial distribution 
of cancer subtypes using PLSR analysis. Similar to Fig. 4, the top three-scored vectors were calculated through PLSR 
analysis on all cancer samples to represent each cancer sample with a three-dimensional vector and a scale 
normalized from 0 to 1. Three ellipsoids were fitted in the same way for better visualization. (b) and (c) Classification 
analyses through SVM-RFE of small cell versus nonsmall cell carcinoma and squamous cell carcinoma versus 
adenocarcinoma on the 35 feature set, respectively. 
For separation of adenocarcinoma from squamous cell carcinoma, a subset of 25 features was chosen 
through feature selection. Classification based on these features showed mixed results with lower (75.5% and 
·71.5%) classification accuracies (Fig. 3.6 (D)). This overlap is not surprising and is in accordance with the clinical 
difficulty in differentiating these two subtypes using morphology alone ( 132). Although separation of non-small 
cell carcinoma from small cell carcinoma has been traditionally adequate for clinical decision-making, this is no 
longer the case. Increasingly, definitive diagnosis of histologic subtype, often in conjunction with molecular 
tumor profiling, is needed (133). In this regard, CARS has the potential to allow for real-time identification of 
non-small cell carcinomas, but tissue excision for additional work-up may still be necessary. Particularly, we have 
evaluated the time taken to classify each sample through the three-step process. We concluded that CARS 
imaging together with computerized pattern recognition and classification only takes a mere few minutes to reach 
a final diagnosis in our study. 
By looking at the five parameters used to describe the distribution of each feature, we found that mean and 
skewness play major roles in this 25-feature subset. In comparison, the kurtosis parameters, which measure 
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"peakedness" ofthese distributions, are excluded, falling into the last 10 VIPs. Since all pictures were acquired on 
a 2D scale through optical sectioning, a normally distributed background noise could be introduced to weaken any 
significant peak in a given distribution. For example, the same cell nucleus would be measured as different sizes 
(potentially from zero to the real size) from different imaging depths. As a result, the peak of cell nuclei will be 
less significant, even if the real size is quite uniform. Therefore, difference in kurtosis will be reduced between 
different cancer subtypes, lowering the importance of this parameter. For the same reason, standard deviation and 
entropy may be weakened as well while the mean and skewness are less likely to be affected in reflecting the 
difference between subtypes. One possible solution to avoid these artificial effects is to conduct measurements on 
3D reconstructed data, which will better reflect the real size and distance between cells and lead to potential 
improvement of the accuracy in separating non-small cell subtypes. 
3.4. Conclusions 
In this chapter, we introduced a new approach that integrates CARS microscopy with advanced pattern 
recognition techniques to enable quantitative differentiation of human lung lesions and classification of lung 
cancer subtypes. We demonstrated the utility of the approach in differentiating among normal, benign, and 
malignant lung tissues, as well as different subtypes of cancerous tissue, in a manner that can be both visualized 
and quantified. Diagnostic features were chosen according to established pathological standards, enabling direct 
interpretation of the results. These excellent ex vivo results indicate the potential of the reported diagnostic 
system for the evaluation of fresh tumor specimens during intraoperative procedure or image-guided biopsy 
without waiting for pathological staining, this would result in accelerated diagnosis or improved clinical decision 
making. In addition, the demonstration of the strategy is a necessary step toward in vivo diagnosis of pre-
cancerous and cancerous lung lesions. In summary, the reported computerized and label-free imaging strategy 
could potentially improve and fundamentally change diagnostic approaches to early-stage lung cancer by offering 
an efficient way to characterize different types of lesions, enabling medical practitioners to obtain essential 
information in real time and, when coupled with fiber-based imaging when available, would reduce the need for 
excisional tissue biopsies while facilitating definitive treatment. 
58 
4. Differential Diagnosis of Breast Cancer 
1. This chapture is adapted from the following publications: 
a. Yaliang Yang, Fuhai Li', Liang Gao", Zhiyong Wang, Michael J. Thrall, Steve Shen, Kelvin Wong, Stephen Wong, "Differential 
Diagnosis of Breast Cancers using Quantitative, Label-Free and Molecular Vibrational Imaging", 2011 Aug 1;2(8), Biomedical Optics 
Express ('Equal contributions) 
b. Yaliang Yang, Liang Gao, Zhiyong Wang, Michael Thrall, Pengfei Luo, Kelvin Wong, Stephen Wong, "Label-free imaging of human 
breast tissues using coherent anti-Stokes Raman scattering microscopy", Proceeding of SPIE, Vol. 7903, 20 II 
2. I performed part of the leading role in this project by helping design the project, working on data interpretation and analysis and 
drafting the manuscript. The actual experiments and a major part of data processing were performed by my collaborators. Given my 
contributions to this project, I served as an equally contributed first author on the journal paper. 
4.1. Introduction 
Breast cancer is the second leading cause of cancer-related deaths in women (1 in 8 women; about 13%) and 
accounts for approximately one-third of all cancers diagnosed among women in the United States (47). The 
American Cancer Society estimated 230,480 new cases of invasive breast cancer and 57,650 new cases of in-situ 
breast cancer, as well as approximately 39,520 breast cancer-related deaths, in women in 2011 (134). Therapeutic 
decisions are based on imaging studies and pathologic diagnosis, neither of which has perfect sensitivity or 
specificity (135, 136). As the gold standard for clinical diagnosis, surgical pathology examines multiple 
histological features of tissues or cells (cell size, shape, and density or the formation of specific patterns) removed 
by surgeons or radiologists to characterize cancer lesions and their subtypes. The diagnostic process usually 
begins with a breast biopsy of either abnormal calcification or mass lesion, which is often performed by open 
surgery that removes the entire lesion, or by minimally-invasive core-needle biopsy that removes 5-12 cores of 
tissues to ensure adequate sampling. The excised tissues are then fixed, sliced, stained, and finally examined 
under a microscope by pathologists to make a diagnosis, resulting in a turnaround time ranging from hours to days. 
Frozen sections are more rapid, but are usually not performed on breast specimens because fatty tissue does not 
perform well in this technique. As a result of the long turnaround time for conventional histology, another 
procedure is often necessary because biopsies need to be repeated or margins need to be re-excised. Resulting 
delays or misdiagnosis in this process could directly lead to a missed opportunity to treat lesions early or 
unnecessarily aggressive therapies with harmful side-effects. Since diagnosis of cancer lesions plays a critical role 
in breast cancer prevention and treatments, a more rapid diagnostic technique could potentially reduce the number 
of repeated procedures while facilitating the whole process by allowing on-the-spot recognition of inadequate 
biopsies or positive margins. 
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In light of this, a variety of optical imaging techniques, such as fluorescence and Raman spectroscopies, 
have been explored to improve breast cancer diagnosis. Fluorescence spectroscopy has been demonstrated as a 
useful tool in breast disease correlations through ex vivo imaging experiments (137-139). Although fluorescence 
imaging provides relatively high signal-to-background ratio, the small number of endogenous fluorophores in 
breast tissue and their overlapping spectra limit its applications (64). Raman spectroscopy is another modality that 
has been investigated for disease diagnosis. It functions to identify disease lesions by capturing intrinsic chemical 
changes within tissues (64). Previous study has successfully demonstrated its usefulness in identifying carcinomas 
by having a sensitivity of94%, a specificity of96% and an overall accuracy of86% (65). However, this technique 
is limited by its long acquisition time (> 1 s/pixel) with high excitation power, preventing its applications from 
fast scanning of large surface areas with high spatial resolution (66). Collectively, then, there is considerable 
interest in developing a fast, less invasive, and more objective method for the screening and diagnosis of breast 
cancer (140). 
As a molecular imaging technique, CARS microscopy has been demonstrated as a powerful tool for label~ 
free imaging with sub-wavelength spatial resolution (141-144). CARS imaging formulates contrast by probing 
resonances from specific chemical bonds in unstained samples, enabling its chemical selectivity. In the field of 
cancer detection, a recent study showed the use of multiplex CARS for interferometric imaging of breast cancer 
for identification of cancer margins (67). In this paper, breast tissues were evaluated using their spectrum profile 
for construction of a digitized image for identification of tumor boundaries. The strategy was based on the 
chemically-selective modality of the CARS technique, but did not use its high spatial resolution in capturing 
cellular structures. 
Current pathology examination of stained breast biopsy samples focuses on changes in such cellular and 
histological features as cell size, cell-cell distance, and formation of fibrous structures (114). Accurate 
identification of these features will lead to delineating the type of lesions for definitive treatment. However, 
conventional pathology examination is still subject to interobserver variations (136). The CARS technique 
provides high-resolution images which can clearly detect individual cells without using any exogenous agent to 
stain tissue. Therefore, we hypothesized that a cell/tissue pattern recognition method could be developed using 
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established pathological workup and diagnostic features as a basis for the quantitative classification of different 
types of breast lesions, leading, in tum, to a fast examination strategy for the analysis of breast cancer samples. 
Accordingly, in this chapter, such disease-related features as cell size, cell-cell distance and presence of fatty and 
fibrous structures were used for classification analysis. Cancerous lesions were initially separated from normal 
tissue and benign proliferative lesion using visual features such as the presence of fatty and fibrous structures. To 
further separate cancer subtypes, cellular features related to the morphology and distribution of cancer cell 
nucleus were extracted from ex vivo CARS images of human breast tissues, including ductal carcinoma in-situ 
(DCIS), invasive ductal carcinoma (IDC), and invasive lobular carcinoma (ILC), and used to quantitatively 
characterize different cancer subtypes through a classification strategy based on machine learning techniques. To 
the best of our knowledge, this pilot study demonstrates the first diagnostic platform with label-free and fast 
imaging properties with the potential to distinguish breast cancer from normal and benign tissues on the basis of 
quantitative cellular and tissue features applied to a computerized classification system. 
4.2. 
4.2.1. 
Methods and Materials 
Sample preparation 
Breast tissues were obtained from female patients undergoing surgical biopsy and surgery at TMH following 
Office of Human Subjects Research approval from TMHRI. The excised tissues were immediately snap-frozen in 
liquid nitrogen for storage. A total of nineteen patients were enrolled in this study, including 4 cases of 
fibroadenoma, 2 cases of DCIS, 8 cases of IDC (2 cases of intermediate-grade (IG-) IDC and 6 cases of high-
grade (HG-) IDC), and 5 cases ofiLC. Twelve normal tissue samples were also collected from the same patients 
with IDC and ILC. Frozen tissue samples were thawed at room temperature and then imaged ex vivo using the 
CARS microscope, which is described in Chapter 2. Two to five sampling points were imaged for each specimen 
and a total of 48 sampling poiQts were examined (9 from DCIS, 11 from IG-IDC, 17 from HG-IDC and 11 from 
ILC patients). At each sampling point, three images were acquired from different imaging depths, resulting in a 
total of 144 images were used in this study. After CARS imaging, imaged places were marked with India blue, 
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and samples were fixed in buffered formalin, sliced 5-J.Lm thick, and finally stained with H&E, as a standard 
control of the disease type. 
4.2.2. Image acquisition 
Tissue samples were placed on a 170-J.LID cover slip and inverted on a rubber ring to form a sample chamber to 
avoid possible compression and associated morphologic changes of tissues during imaging (145). The pump and 
the Stokes wavelengths were tuned to reach a beating frequency of 2,845 cm·I, probing the symmetric CH2 
stretching band. The CARS signal at 663 nm was collected using a backward (Epi-) detection scheme. Image 
processing was performed using the Olympus Fluoview V5.0 software. Z-stack images with 1-J.LID step size were 
acquired at two digital zooms. Low power views at zoom 1.5X ( ~ 0.30 J.lllllpixel) with overall architectural 
information would allow us to clearly observe morphological features, while high power views at zoom 3.0X ( ~ 
0.15 J.lllllpixel) with detailed cellular information would be used for precise segmentation of cells. Average power 
on sample was~ 70 mW and~ 35 mW for the pump and Stokes beams, respectively. This power combination is 
higher than that typically used for CARS imaging. It is due to the fact that solid tumor tissues normally possess a 
lower lipid level than normal tissues. As a result, a higher excitation power is required to provide enough image 
contrast for observation of cellular structures in tumor tissues. The acquisition time was about 4 seconds per 
frame with 512 x 512 pixels. Bright-field images of their corresponding H&E slides were captured by using an 
Olympus BX51 microscope and examined by a pathologist to determine the type of lesions as a standard control. 
4.2.3. Quantitative image analysis 
Cell nucleus segmentation and boundary detection was performed using the same analytical approach as that is 
described in Chapter 1. An average of 27 cells for DCIS, 18 cells for IG-IDC, 16 cells for HG-IDC, and 12 cells 
for ILC per image were used for parametrical calculation. Figure 4.1 (B) provides an illustration of cell nuclear 
segmentation of an IDC sample shown in Figure 4.1 (A). 
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Figure 4.1 A CARS image (A) from the Z-stacks of an IDC sample, showing cell nuclei segmentation (B), Voronoi 
tessellation (C), and Delaunay triangulation (D). Image size: 120 x 120 :fit 2 . 
Validation of cell nuclei segmentation: One hundred cells were randomly selected from 10 CARS images 
for each subtype of four breast cancer lesions: DCIS, IG-IDC, HG-IDC, and ILC, to validate the semi-automated 
segmentation algorithm. The semi-automated segmentation results were compared with the manual segmentation 
results by calculating three scores: precision, recall and f-score as those defined in Chapter 3. Figure 4.2 shows 
the validation results of cell segmentation in terms of precision, recall and fscore . It can be seen that all three 
indexes are close to 90% for the 400 individual nuclei from four cancer subtypes, indicating the high accuracy of 
our cell nuclear segmentation algorithm. 
4.2.4. Extraction of disease-related features 
We designated seven pathological features to characterize the difference among breast cancer subtypes: nuclear 
size, lengths of major (long) and minor (short) axes of cell nucleus, Voronoi tessellation (Fig. 4.1 (C)) size (121, 
146), as well as average, major and minor neighbor distances of cells in the Delaunay triangulation graph (Fig. 4.1 
(D)) (147, 148). Moreover, five parameters, including mean value, standard deviation, skewness, kurtosis, and 
entropy, were employed to evaluate the distribution of each feature. Consequently, a total of thirty-five features 


















Figure 4.2 Validation results of cell nuclear segmentation. DCIS: ductal carcinoma in-situ , IG-IDC: intermediate-grade 
invasive ductal carcinoma, HG-IDC: High-grade invasive ductal carcinoma, ILC: invasive lobular carcinoma. 
Differential diagnosis analysis 
We performed two analyses to investigate the separation of cancer subtypes: PLSR (124, 125, 149, 150) and 
semi-supervised learning (SSL) classification. PLSR is used for 3-D data visualization, and SSL is used to 
classify different subtypes of breast lesions. The idea of SSL ( 151 , 152) is to make use of both the training data 
and the data structure information embedded in the unlabeled data. SSL is straightforwardly used to smooth 
classification results . In other words, SSL prefers that the nearby samples should belong to the same class, and the 
labeled samples transfer their label information outward to their nearby unlabeled neighbors gradually layer by 
layer. An intuitive example is the two moons shape data provided in ( 151, 152). Mathematically, the processes of 
SSL are as follows. Given m are data points X= {x"x2 , . .. ,x, } which belong to c class ( C = {1,2, .. . ,c} ). The first 
m 1 data points are labeled as Y; E C, and the other data points are unlabeled. SSL analysis finds a non-negative 
matrix Fmc, which will be used to generate the labels of unlabeled data points, such as Y; = argmax1sc ~ . The cost 
function of Fmc is defined as follows (151 , 152): 
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points. On the right-hand side of the above equation, the first term is the smoothness function which requires the 
neighboring data points to belong to the same class, while the second term is the fitting function which limits the 
labeled data points in order to be consistent with their original labels. Then the optimal F* satisfies 
F*=argmaxF<b(F). Differentiating <I>{ F) atF*, the equation 
Equation 4.2 
(acl>l BF)jF=F· = F*-SF*+,u(F*-Y) = 0 can be obtained, wheres = n-112WD- 112 • Therefore, 
Equation 4.3 
F*-SF*/(1+ ,u)- ,uY 1(1+ ,u)=O. Letting a=ll(1+u) and P=,ul(l+u), the relation 
Equation 4.4 
F* = /3(1 -ast Y can thus be obtained (151, 152). 
To validate the classification algorithm, a leave-one (patient)-out cross-validation analysis was conducted. 
In this process, the data from one of the patients were used for testing, while the remaining patients' data were 
used to train the classifier. Since three z-stack CARS images were captured for each sample, we used the voting 
method to manage the conflicting results among individual stacks. The sample's subtype was determined 
according to the classification results of the majority of the z-stacks. For example, if two of three z-stacks were 
classified into the same class, this sample would be recognized into that class regardless of the result from the 
third stack. 
4.3. Results and Discussion 
4.3.1. CARS Images of breast tissues 
Fig. 4.3 shows· a comparison of CARS images of normal breast tissue, benign proliferative lesion and carcinomas 
with their H&E stained photomicrographic images. On H&E stained images, normal breast tissues predominantly 
consist of adipose and fibrous structures (Fig. 4.3 (B) and 4.4 (D)). These structures possess strong CARS signals 
65 
and can be clearly recognized in CARS images, as shown in Fig. 4.3 (A) and 4.3 (C), respectively. No obvious 
cells were identified in the normal tissues with CARS, possibly because of the overwhelming CARS signals from 
the fat and fibrous tissue components. Fibroadenoma is a common benign biphasic fibroepithelial tumor. One of 
its unique features is the intracanalicular pattern, in which the compressed duct shows linear branching pattern 
with slit-like lumen, as indicated by the arrow in the H&E stained image shown in Fig. 4.3 (F). The same pattern 
is also clearly identified in the CARS image, as indicated by the arrow in Fig. 4.3 (E). 
Figure 4.3 (H) shows the H&E stained image of a solid subtype of DCIS. The tumor cells are confined 
within the basement membrane and nearly fill the entire duct space. There are prominent cytoplasmic borders 
with sharp outline. These features are also presented in the CARS image shown as Fig. 4.3 (G). Similarly, IG-IDC 
consists of tumor cells growing in cords, nests, tubules, and anastomosing cell clusters, invading into the 
surrounding stroma, as shown in Fig. 4.3 (J). All these features are distinctly observed in the CARS image shown 
in Fig. 4.3 (1). The CARS and H&E stained images of HG-IDC are shown as Fig. 4.3 (K) and 4.3 (L), 
respectively, in which tumor cells are arranged singly or in small clusters, but without noticeable tubule or gland 
formation. Fig. 4.3 (N) shows an H&E stained image of a classic ILC, with characteristic infiltrative pattern with 
single or rows of cells (Indian filing) invading into the stroma. This pattern is clearly presented in the CARS 
image, as shown in Fig. 4.3 (M). It is worth noting that in some foci, the single filing infiltrative pattern of ILC is 
inconspicuous, and the tumor cells may just be dispersed in the stroma in an irregular fashion. 
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Figure 4.3 CARS images of human breast tissues taken at Raman shift of 2845 cm·1 and their H&E stained images 
from similar regions. Images of (A) adipose and (C) fibrous structures in normal tissues and their H&E stained images 
(B) and (D). Image (E) of a kind of fibroadenoma (a benign lesion) and its H&E stained image (F) , in which a 
compressed duct can be clearly seen as a linear branching pattern with slit-like lumen, as indicated by the arrow. Image 
(G) of DCIS and its H&E stained image (H). Images of (I) IG-IDC and (K) HG-IDC and their H&E stained images (J) and 
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Figure 4.4 Distributions of the seven features of four subtypes of breast cancer: (A) nuclear size, (B) major and (C) 
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Figure 4.5 Spatial distributions of four subtypes of breast cancer using the 35-feature set under PLSR analysis. 
4.3.2. Differential diagnosis of breast cancer 
In most cases, histological evaluation alone is sufficient to separate in-situ carcinoma from invasive carcinomas 
and to separate ductal and lobular carcinoma subtypes. However, in some instances, the differential diagnosis of 
histological subtype of breast cancer may be difficult and cannot be reliably made with conventional H&E 
staining of histological sections, even by an experienced pathologist. Therefore, using breast tissue samples with 
histologically well-characterized lesions by H&E staining, we explored whether an algorithm could reproduce 
identical or near-identical morphological characterizations using CARS images. Figure 4.4 provides the 
distributions of the seven features for four subtypes of breast cancer. From Figure 4.4 (A), (B) and (C), it can be 
seen that IG-IDC has larger nuclear size and longer major and minor radii with wider distribution ranges than 
other subtypes. HG-IDC has narrower distribution range while IG-IDC has wider distribution range than other 
subtypes in Voronoi tessellation size, as shown in Figure 4.4 (D). IG-IDC and ILC have longer average and minor 
neighbor distances with narrower distribution ranges than other subtypes, as shown in Figure 4.5 (E) and (G). IG-
IDC has longer major neighbor distance with a wider distribution range than other subtypes, as shown in Figure 
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4.4 (F). Figure 4.5 shows the global spatial distributions of four subtypes of breast cancer using PLSR analysis. 
Here, it can be visually seen that DCIS is mostly separated from IG-IDC and ILC but partially overlaps with HG-
IDC, and ILC is well separated from other subtypes while IG-IDC and HG-IDC have partial overlapping. 
The quantitative analytical results of differential diagnosis of breast cancer subtypes are listed in Table 
4.1, while the classification overview is illustrated in Figure 4.6. The accuracies of separating in-situ carcinoma 
from invasive carcinoma are shown in Table 4.1 (A). While I 00% of the in-situ carcinoma is correctly identified 
and 18% of the invasive carcinomas are erroneously classified as in-situ carcinoma, having an overall accuracy of 
92%. This result could be visualized in the 3-D distribution of these cases in Fig. 4.5. Based on this result, a 
classification algorithm was developed to separate DCIS from IG-IDC and ILC, and the results are shown in 
Table 4.1 (B). By this algorithm, 96% of DCIS and 95% oflG-IDC and ILC samples are correctly classified with 
an overall accuracy of 96%. The accuracies of separating !DC from ILC are shown in Table 4.1 (C). They are 
100% separated from each other, which is also illustrated in the 3-D visualization results in Figure 4.6. As shown 
in Table 4.1 (D), 80% of IG-IDC and 85% of HG-IDC were correctly separated with an overall accuracy of 83%. 
Figure 4.6 Overview of the classification scheme. 
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Table 4.1 Classification accuracy of separating cancer subtypes from each other 
(Accuracy= (true positive+ true negative) I total testing samples) 
4.3.3. 











































In this chapter, we have demonstrated the feasibility of using CARS microscopy to distinguish breast cancer from 
normal tissue and benign proliferative lesion, as well as different cancer subtypes. High quality ex vivo images 
were obtained for normal, benign (fibroadenoma), DCIS, IDC and ILC breast tissues by using a custom-built 
CARS microscope. Our results show that CARS microscopy is capable of characterizing breast tissue structures 
and cell types in a manner similar to H&E staining of conventional histological sections. On CARS images, 
normal breast tissues present predominantly adipose and fibrous structures, while fibroadenomas possess unique 
morphological features in accordance with pathological criteria On the other hand, cancer tissues exhibit distinct 
cellular features with high cellularity. These disease-related features can be used to distinguish cancer lesions 
from normal and benign tissues. In addition, the cells of different cancer subtypes also present unique features, 
e.g., the cords and tubules for IG-IDC, the solid pattern for HG-IDC, and the single filing pattern for ILC. CARS 
microscopy was also shown to discriminate these cellular features to further separate cancer subtypes. A 
computerized platform was developed to perform nuclear segmentation and classification of different types and 
subtypes of breast lesions. Our results showed a good distinction of cancer from normal tissues and benign 
lesions, as well as cancer subtypes. Compared to H&E analysis, however, our approach presents a much faster 
strategy and eliminates the need for sample processing and the use of exogenous contrast agents, thus 
significantly reducing diagnostic time. The separation of some breast lesions, such as atypical ductal hyperplasia 
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and DCIS, is more subtle and will likely continue to require conventional histological analysis. Nonetheless, we 
have demonstrated that CARS imaging is reliable, sensitive and specific in discriminating between different 
subtypes of breast cancer, e.g., non-invasive in-situ vs. invasive, different histological subtypes, e.g., DCIS vs. IG-
IDC & ILC, and different histological grades of carcinoma, e.g., intermediate vs. high grade. Because they have 
direct impact on prognosis, choice of treatment modalities and monitoring response to therapy, such distinctions 
are critical. 
The detailed reasons for further separating cancer subtypes from each other are as follows. I) Separating 
in-situ carcinoma from invasive carcinoma: in-situ carcinomas have an excellent prognosis and are generally 
treated with lumpectomy and sometimes radiation, whereas invasive carcinomas have poorer prognosis and are 
generally treated with surgery (lumpectomy or mastectomy with or without lymph node removal), chemotherapy, 
and sometimes radiation. 2) Separating ILC from IDC: Rates of mastectomy compared to breast-conserving 
surgery in ILC are slightly higher than for IDC (153), and ILC is also not a good candidate for neoadjuvant 
chemotherapy because pathologic complete response-rates are much lower for ILC (3%) than for IDC (15%) 
(154). Two large series with long follow-up observation (155, 156) have revealed trends showing that the 
prognosis of ILC in the early years is somewhat better than the prognosis for IDC, while this trend is reversed in 
later years. That is, after about 6 years, relapse of ILC catches up with IDC. 3) Separating IG-IDC from HG-IDC: 
High-grade means that tumor cells are poorly differentiated in the Bloom-Richardson grading system, and poorly 
differentiated cancers have a worse prognosis. Patients with poor prognosis are usually offered more aggressive 
treatment, such as extensive mastectomy and one or more chemotherapy drugs, while patients with a good 
prognosis are usually offered less invasive treatments, such as lumpectomy and radiation or hormone therapy. 
Sometimes identifying cancer subtypes is difficult using the CARS technique because the histological 
features may be difficult to observe based on the limited field of view in the CARS image. As an adjunctive • 
diagnostic approach, the quantitative analysis of cancer cells facilitates more accurate identification of cancer 
subtypes. To enable the implementation of this quantitative approach, cell nucleus segmentation was performed, 
followed by extraction of seven pathology-related features with 5 evaluation indexes, a total of 35 features, to 
describe each image. The distributions of seven features for four subtypes of breast cancer are shown in Fig. 5, 
72 
which indicates differences among subtypes. Moreover, the global spatial distributions of four subtypes using the 
35-feature set under PLSR analysis are shown in Figure 4.6, and the results show the robustness of the algorithms 
in separating cancer subtypes. Finally, a quantitative analysis of the differential diagnosis of cancer subtypes was 
conducted, and the results show high accuracies for the separation of cancer subtypes. 
As a future study direction, 3D imaging and differential diagnosis of breast cancer using CARS 
microscopy is attractive. It can provide more information than 2D images, and allow tracking of features from 
different levels to identify 3D architecture and low contrast structures that are difficult to appreciate from single 
images (157). The 3D imaging capability of the CARS technique makes this aim achievable based on its 
nonlinear nature. Nonetheless, prospective studies with a larger sample size are necessary for subtypes of cancer 
(DCIS in particular) to further evaluate the efficacy of our method. Current study is still limited by the number of 
samples and might experience a larger bias. 
4.4. Conclusions 
We demonstrated the feasibility of integrating label-free CARS microscopy and quantitative data analysis to 
classify breast cancer from normal tissue and benign proliferative lesion, as well as further separate cancer 
subtypes. This study suggests that quantitative CARS microscopy has the potential to be used as a routine 
examination tool to rapidly identify breast cancer ex vivo. For future studies, the label-free and fast imaging 
properties of CARS could propel this technique to become a non-invasive approach for in vivo and real-time 
diagnosis of breast cancer without the need for histological staining or administration of exogenous contrast 
agents. Although conventional histological analysis would remain the gold standard and would remain necessary 
for difficult cases requiring the analysis of subtle pathologic features or immunohistochemistry markers, the fact 
that CARS seems to be able to delineate major diagnostic entities shows its promise to greatly increase the 
amount of information timely available to patients and physicians during biopsy or excision procedures. 
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5. Suppression of Four-Wave-Mixing in Multimode Fibers for Fiber-Delivered CARS 
Imaging 
I . This chapter is adapted from the following publications: 
a. Zhiyong Wang, Liang Gao, Pengfei Luo, Yaliang Yang, Ahmad Hammoudi, Kelvin Wong, Stephen Wong, "Coherent anti-Stokes 
Raman scattering microscopy imaging with suppression of four-wave mixing in optical fibers", Vol. 19, No.9, 2011, Optics Express 
(selected for publication in Virtual Journal for Biomedical Optics) 
b. Zhiyong Wang, Yongjun Liu, Liang Gao, Yuanxin Chen, Pengfei Luo, Kelvin Wong, Stephen Wong, "Use ofmultimode optical fibers 
for fiber-based coherent anti-Stokes Raman scattering microendoscopy imaging", Vol. 36, No. 15, August I, 2011, Optics Letters 
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5.1. Introduction 
As shown in the previous chapters, the CARS imaging technique has been demonstrated as a powerful tool for 
label-free imaging and optical diagnosis of potential cancers. It offers many advantages including chemically 
selective contrasts, high sensitivity, rapid acquisition rates, and sub-wavelength spatial resolution (2, 158). 
Especially, the development of computerized pattern recognition software system further strengthens its 
advantage in identifying cellular structures by quantitatively calibrating pathologically-related features for 
diagnostic evaluations. The combination of CARS with the computerized· software thus provides an unparalleled 
opportunity of translating this strategy for real-time clinical applications. Moving forward in this direction, the 
development of a miniaturized fiber optical imaging probe is essential for intraoperative Fiber-optic fluorescence 
imaging interventions. An essential component of this probe is an optical fiber which functions to deliver the 
excitation lasers for CARS generation and to collect resulted CARS signals. Such a system has increasingly 
attracted research attention, because of its flexibility for optical alignments as well as the importance for in vivo 
microendoscopy applications (88, 89, 159). 
Therefore, the goal ofthis chapter is to develop a flexible and stable optical fiber delivery system as those 
used in confocal fluorescence endoscopy (160), optical coherence tomography (85, 161), and in vivo endoscopy 
imaging systems (162). So far, SMF (89) and PCF (159) have been successfully demonstrated for use in the 
CARS imaging system. However, in order to satisfy the single-mode condition, the core diameter of the step-
index SMF is limited to ~5f..Lm. Relatively small-sized core makes SMF susceptible to generating nonlinear 
effects, e.g. SPM, which will reshape the spectra of laser pulses. Although the core diameter of PCF is larger than 
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SMF (e.g. ~16f.l1Il for large mode area PCF), the NA ofPCF is usually small (e.g. ---<>.06 for large mode area PCF) 
and, thus, results in difficulty and instability of laser coupling as well as small coupling efficiencies (< 30%) 
(159). To address these issues, multimode fibers (MMF) may be a good candidate for delivery of ultrafast pulses 
for CARS imaging. Compared to SMFs and PCFs, step-index MMFs have larger core diameters, larger NA, and 
larger coupling efficiency. In spite of these advantages, the delivery of two ultrafast pulses in the multimode fiber 
for CARS imaging has not been investigated. 
In this chapter, we investigated the possibility of using standard commercial MMF, Coming SMF28 
fibers, to deliver picosecond excitation lasers for CARS imaging. We first demonstrated the existence of the 
FWM effect in optical fibers. When the pump and Stokes waves travel in the same fiber with temporal 
overlapping, strong FWM signals are generated at the anti-Stokes frequency, mFWM, exactly matching CARS 
frequency (OJcAR?2mp - ms). If this FWM signal enters the detection system together with the desired CARS 
signal, the CARS image quality will be severely affected due to the FWM background noises. To address this 
question, a longpass dichroic mirror, or a longpasslbandpass filter is usually employed to block the unwanted 
FWM signals for CARS microscopy imaging (89, 97). Nevertheless, most endoscopy systems utilize the same 
fiber for delivery of excitation lasers and collection of returned emission signals for detection. In such case, the 
implementation of a dichroic mirror or a filter will block not only FWM signals but also the returned emission 
signals for detection. Therefore, it is desirable to build a FWM-suppressing mechanism to reduce the FWM 
background noises to realize a fiber-based CARS imaging system. To solve this challenge, we further 
demonstrated a polarization-based mechanism for suppression of FWM signals in the delivery fiber. Polarization 
maintaining fibers (PMF) were used as the delivery fiber to ensure stability of the state of polarization (SOP) of 
lasers. The pump and Stokes waves were coupled into PMFs at orthogonal SOPs along the slow and fast axes of 
PMFs, respectively, resulting in a significant reduction of FWM signals generated in the fiber. At the output end 
ofPMFs, a dual-wavelength waveplate was used to realign the SOPs of the two waves into identical SOPs prior to 
their entrance into the CARS microscope. Therefore, it allows the pump and Stokes waves with identical SOPs to 
excite samples at highest excitation efficiency. 
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Our experimental results showed that this polarization-based FWM-suppressing mechanism can 
dramatically reduce FWM signals generated in PMFs up to approximately 99% with a microscopy setup. 
Meanwhile, the PMF -delivered CARS microscopy system with this mechanism can still produce high-quality 
CARS images. Moreover, because this polarization-based mechanism only changes SOP of light, unlike 
aforementioned filter-based mechanism for FWM suppression, it won't block the returned emission signals in the 
delivery fiber for detection in most endoscopy designs. Finally, we developed a MMF-based CARS 
microendoscopy prototype imaging system with the polarization-based scheme for suppression ofFWM signals in 
delivery fibers. MMF was used for both delivery of excitation lasers and collection of returned CARS signals. The 
linearly-polarized pump and Stokes beams were coupled into MMFs at orthogonal SOPs and outputs were also 
orthogonal linearly-polarized lights, resulting in significant reduction ofFWM signals in the fiber. Then, a dual-
wavelength waveplate was used to realign the SOPs of the two beams into identical SOPs prior to their focusing 
on samples, ensuring high excitation efficiency of CARS signals. 
Collectively, this chapter focuses on developing an effective fiber delivery system as an essential 
component for building a CARS microendoscopy system for in vivo imaging. We first identified a FWM 
background in the delivery fiber. Next, a polarization-based FWM suppression strategy was proposed and tested 
for effective suppression of this background on a microscope setup. Last, this strategy was further tested using an 
endoscope prototype, where the same fiber was used both for delivery of the excitation lasers and collection of the 
resulted CARS signal. Therefore, the results in this chapter demonstrate the feasibility of developing a fiber 
microendoscope system for intraoperative CARS imaging. Combined with the previous described morphology-
based pattern recognition platform, our study already demonstrated a substantial potential of translating this 
imaging technique into clinical practice, potentially changing current schemes for cancer imaging and 
intraoperative diagnosis. 
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5.2. Methods and Materials 
5.2.1. Identification of FWM in the Delivery Fiber 
The schematic of our CARS microscopy system is shown in Fig. 5.1 and has been described in Chapter 2. The 
standard communication fiber, Coming SMF28 optical fibers was used in our experiments. The SMF28 worked as 
a MMF below its cutoff wavelength of ~1260nm, and covered our CARS operating wavelength range (i.e. from 
500nm to 11 OOnm). It had a core diameter of ~9.2~m and aNA of 0.14. Because its V -parameter was ~4.34 for 
817nm (pump) and ~3.33 for 1064nm (Stokes), there were approximately 9 core modes for 817nm and 6 core 
modes for 1064nm based on calculated results from a estimation equation (NzV2/2) (163). In our experiments, the 
coupling efficiency was about 72% for the pump (817nm) and 64% for the Stokes (1064nm), which were coupled 
into the SMF28 using a 10 ? objective. The autocorrelator used to measure auto/cross-correlation function curves 
was an autocorrelator for APE Levante Emerald OPO (High-Q Laser, Hohenems, Austria). The optical 
spectrometer used to measure the optical spectra was 86142B optical spectrum analyzer (Agilent Technologies 
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Figure 5.1 Schematic of our CARS microscopy system with (a) pump and Stokes beams coupling into a fiber by a 
microscopy objective and collimated by a microscopy objective; (b) Configurations of the CARS microscope. 
We first examined the FWM effect induced by the pump (817nm) and Stokes (1064nm) waves 
simultaneously propagating in a 1-meter long SMF28. In addition, we verified the FWM effect using our CARS 
microscopy. FWM signal was measured using an optical spectrometer HR4000 (Oceanoptics, Inc) right after the 
fiber. This system provided better sensitivity than Agilent OSA in the range of visible wavelengths. Next, instead 
of inserting the 1-meter SMF28 before the entrance of the CARS microscopy, we mounted it directly under the 10 
? (NA 0= 0.25, Newport) objective and captured the backward FWM (or nonresonant CARS) images from the 
proximal end of the fiber. The Epi-CARS channel was used with a bandpass filter (hq660/40m-2p, Chroma 
Technology Corp). Powers ofthe pump and the Stokes at the proximal end ofMMF were 200 mW and 100 mW, 
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respectively. Finally, we tested the SMF28 to deliver ps lasers for CARS imaging. The setup is shown in Figure 
5.1. Emerging from the dichroic mirror (DMI ), the pump (817nm) and Stokes (1 064nm) waves were coupled into 
a 1-meter long SMF28 by a 10? Newport objective. After passing the fiber, the two waves were then collimated 
by another 20 ? Newport objective. A 750nm long-pass filter (FEL0750, Thorlabs Inc.) was used to eliminate the 
FWM (663nm) signals generated in the SMF28 before the microscopy system. The pump and the Stokes waves 
were tuned to 40 mW and 20 mW for CARS imaging. We characterized the performance of the setup by imaging 
calibrated 1 OJ.llll polystyrene beads (PEB), which generated strong resonant CARS signals at the aliphatic 
symmetric CH2 stretch (~co= 2845cm-1). 
5.2.2. Polarization-based FWM Suppression Strategy 
The experimental setup is illustrated in Figure 5.2. A combination of one 0-A. waveplate (Thorlabs Inc.) and one 
linearly polarizer (Thorlabs Inc.) is placed in both pump and Stokes arms, which is used to rotate the orientation 
of the linearly polarization states of two waves before they are coupled into fibers. A customized dual-wavelength 
multi-order waveplate (Sinoceramics (USA), LLC.) is placed at the output end of PMFs to realign SOPs of two 
waves into identical SOPs in prior to their entrance into the CARS microscope. The dual-wavelength waveplate is 
designed to achieve that orthogonally polarized components' phase delay difference between the pump and Stokes 
waves is 1t, for instance, 0-A.@ pump & 1-A.@ Stokes, or 1-A.@ pump & 0-A.@Stokes. In our experiments, we 
adopted the 0-A. @ pump & 1-A. @ Stokes waveplate for all experiments because there was no discemable 
difference in terms of CARS image quality between these two types of waveplates in our tests. The pump and 
Stokes wavelengths were tuned to 817 nm and 1064nm, respectively, resulting in a 2845 cm-1 Stokes shift, 
matching with the Stokes shift of the CH2 stretch vibration. 
Nufem panda-style PMF (PM1300-HP, Thorlabs Inc.) was used in our experiments. Its microscopic 
picture is illustrated as an inset of Figure la. PM1300-HP is a MMF for the pump (817nm) and Stokes (1 064nm) 
beams because its cut-off wavelength is -1200nm, and we have previously demonstrated the use of MMF for 
laser delivery for CARS imaging [15]. It had a mode field diameter of -9.5J.1m and a cladding diameter of 125Jllll. 
In our experiments, the coupling efficiencies were about 70% and 60% for the pump and Stokes beams coupled 
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into either the fast or slow axis of PMF by a I Ox objective. The polarimeter used to measure SOPs of lasers was 
TXP Polarimeter with external measurement heads (Thorlabs Inc.). The autocorrelator used to measure 
auto/cross-correlation function curves was an autocorrelator for APE Levante Emerald OPO (High-Q Laser, 
Hohenems, Austria). The optical spectrometer used to measure the optical spectra was 86142B optical spectrum 
analyzer (Agilent Technologies Corp., USA) and HR4000 (Oceanoptics Inc., USA). 
It is well-known. that the efficiency of a FWM process in fibers highly depends on the SOPs of input lights 
(163-167). Because the pump and probe beams are identical (i.e. OJp = mp) in our CARS system, our case is 
defined as partially degenerate FWM. When SOPs of two input lights are orthogonal to each other in partially 
degenerate FWM, the efficiency of FWM process in fibers will be approaching to zero because of polarization 
effect (166). In our experiments, we first examined the polarization effect on FWM generations in the 1-meter 
PMFs. To separately control input SOPs of the pump and Stokes waves, aD-A. waveplate was used to transfer the 
linearly polarized light into circularly polarized light in both pump and Stokes arms. Then, a linear polarizer was 
used to select a desired input orientation of linearly polarized light coupling into PMFs for both pump and Stokes 
beams. In our first experiment, once the pump beam was coupled into the fast axis of PMFs, we rotated the linear 
polarizer at the Stokes arm to change the orientation of linear polarizations of the input Stokes beam with a step of 
I 0°. Meanwhile, we recorded output FWM spectra from PMFs using an Oceanoptics HR4000 optical 
spectrometer. Similarly, we examined the FWM spectra in three additional scenarios: the pump beam coupling 

























Figure 5.2 Schematic of our PMF-delivered CARS microscopy system with (a) pump and Stokes beams coupling into a 
PMF and a dual-waveplate to rotate polarization states of output lasers; (b) configurations of the CARS microscope. 
Afterwards, we aimed to demonstrate that the PMF-delivered CARS microscopy system with the 
polarization-based FWM-suppressing mechanism can still produce high-quality CARS images. The setup is 
shown in Figure 5.2. The linearly polarized pump and Stokes waves were coupled into either slow or fast axis of 
! -meter PMFs. After passing the fiber, the two waves were then coll imated by another lOx objective. Prior to the 
entrance of the CARS microscope, a dual-wavelength waveplate designed for the pump and Stokes wavelengths 
was used to realign SOPs of two waves back to identical SOPs. The pump and the Stokes waves were tuned to 40 
mW and 20 mW for CARS imaging. We tested this setup by imaging calibrated I01-1m PEB spin-coated on a glass 
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slide, which generated strong resonant CARS signals at the aliphatic symmetric CH2 stretch (Aro = 2845cm"1). In 
our experiments, we employed the D-A.@ pump & 1-A.@ Stokes waveplate for the following experiments. 
Finally, we assessed the performance of this PMF-delivered CARS microscopy system, with the 
polarization-based FWM-suppressing mechanism, by imaging two types of mouse tissues ex vivo. 
5.2.3. Test of the Polarization-based FWM Suppression Strategy using a MMF-based CARS 
microendoscopy prototype imaging system 
Based on the results in testing the FWM suppression strategy using a microscopy setup, we extended this 
approach to a MMF based CARS microendoscopy prototype imaging system. In this setup, MMF was used for 
both delivery of excitation lasers and collection of returned CARS signals, which is very much close to a real 
scenario of using a fiber-based microendoscope for clinical interventions. Same as the tests performed using the 
microscopy setup, the linearly-polarized pump and Stokes beams were coupled into MMFs at orthogonal SOPs 
and outputs were also orthogonal linearly-polarized lights, resulting in significant reduction of FWM signals in 
the fiber. Then, a dual-wavelength waveplate was used to realign the SOPs of the two beams into identical SOPs 
prior to their focusing on samples, ensuring high excitation efficiency of CARS signals. 
The schematic of our homemade CARS microendoscopy prototype system is shown in Figure 5.3. The 
pump and Stokes beams were overlapped by a time-delay line and a DM #1 in time and in space. A D-A. 
waveplate and a linear polarizer were placed in both pump and Stokes arms for rotating the orientation of the 
linear polarization of two beams. After passing a DM #2 (770dcxr, Chroma Tech.), two beams coupled into the 
optical fiber by a 1 Ox objective #1 at orthogonal SOPs. A fiber optiC polarization controller was used to adjust 
SOPs of lights in case. After collimated by a 1 Ox objective #2, two beams went through a customized dual-
wavelength waveplate (DWW) to realign their SOPs into identical SOPs. The DWW was designed to achieve that 
orthogonally polarized components' phase delay difference between the pump and Stokes beams is 1t, and we 
used a D-A. @ pump & 1-A. @ Stokes DWW. After reflected by a sliver mirror, two beams were focused on 
samples by a 1.2-NA 60x objective lens. Samples were raster scanned by a 2-D scanning stage (Thorlabs). The 
backward (Epi) CARS signals traveled back along the same path and were separated from the excitation beams by 
DM #2. CARS signals were filtered with four 660/40nm bandpass filters and detected by a PMT. ANI USB-6259 
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data acquisition system (DAQ) was used to control the scanning stage and the PMT. A computer was used to 
control the DAQ and process data. Labview was used to program the imaging software. 
X-V translation 
stage 
Figure 5.3 Schematic of our CARS microendoscopy prototype system. 
Corning SMF28 fiber was used, and it is a MMF for the 817nm and 1 064nm beams. Coupling efficiencies 
were ~70% and ~0% for the pump and Stokes beams by a lOx objective. A polarimeter (Thorlabs) was used to 
measure SOPs of lasers. A HR4000 spectrometer (Oceanoptics) was used to measure spectra. It has been proved 
that for any ordinary optical fiber, two orientations of linearly polarized input light can also exit the fiber linearly 
polarized (168). When the ordinary fiber is not disturbed by external environmental changes, these SOPs can be 
stable for hours, particularly for short fiber lengths of ~100 m or less. Moreover, there exist two orthogonal 
linearly-polarized fiber mode pairs at both input and output of the fiber. There are only two solutions for fiber 
modes which make the input and output light both linearly polarized. We assumed that LPm1 and LPoutl represent 
the input and corresponding output linearly polarized modes for one solution, and LPin2 and LPoua represent those 
for second solution. Then, SOPs ofLPm1 and LPin2 are orthogonal to each other, and SOPs ofLPoutl and LPout2 are 
orthogonal also. By utilizing this feature of fibers, we coupled the pump and Stokes beams into SMF28 at 
orthogonal linear SOPs and obtained their outputs at orthogonal linear SOPs. It is known that the efficiency of a 
FWM process in fibers highly depends on SOPs of input lights (166). When SOPs of two input lights are 
orthogonal in degenerate FWM, the efficiency of FWM in fibers will be approaching to zero (166). We first 
examined the polarization effect on FWM generations in a 1-meter SMF28. We set a fixed orientation of linear 
polarized pump at 82° and rotated the orientation of linear polarized Stokes by 180°. 
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Next, we imaged 1 Oj.im PEB on a glass slide to test the performance of the system in producing high quality 
CARS images. We acquired CARS images at three different polarization configurations with constant detection 
conditions with a pixel dwell time of- 3 ms: (1) parallel-linearly polarized pump (100mW) and Stokes (100mW) 
beams coupled into 1m SMFs without the DWW insertion; (2) orthogonal-linearly polarized pump and Stokes 
coupled into 1m SMFs without the DWW insertion; and (3) orthogonal-linearly polarized pump and Stokes 
coupled into 1m SMFs with the DWW insertion. 
5.3. Results and Discussion 
5.3.1. Identification of FWM in the Delivery Fiber 
We found weak anti-Stokes generations at 663 nm right after the fiber. It matched the 2845 cm-1 anti-Stokes shift 
of the CH2 stretch vibration. Therefore, it would result in spurious CARS signals and background noise in the 
imaging system. The zero-dispersion wavelength of fibers plays an important role in the FWM behavior (169, 
170). For SMF, the FWM phase-matching condition is difficult to be met for the frequency components shifted by 
more than 3000 cm-1 from zero dispersion wavelength of the fiber (169, 170). However for MMF, the FWM 
phase-matching condition is relaxed by the easiness of satisfying the phase-matching condition with pump, Stokes 
and anti-Stokes waves which propagate in different modes (164, 165). For instance, the anti-Stokes wave at the 
fiber mode LP21 can be generated by the combination of the pump (LP01), the pump (LPo2) and the Stokes (LPu) 
(164, 165). As a result, more fiber modes exist in the fiber, more diverse mode combinations will exist to satisfy 
the FWM phase-matching condition, generating stronger FWM signals. Thus, MMF is more likely to satisfy the 
phase-matching condition to generate the FWM signals than SMF. In our case, although the anti-Stokes (663nm, 
-7450cm-1) wavelength was far away from the zero dispersion wavelength of the SMF28 (i.e. 1310nm), SMF28 
can still easily satisfy the FWM phase-matching condition because there were approximately 9 fiber modes for 
817nm and 6 fiber modes for 1064nm existing in SMF28. Figure 5.4 (C) shows a typical normalized measured 
FWM (663nm) wave spectrum output from a 1-meter long SMF28. In our experiment, a clear peak was observed 
at 663nm while no other new peaks occurred when the pl)mp (817nm) and Stokes (1064nm) waves propagated in 
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SMF28 simultaneously. Also, we noted that anti-Stokes signals (663 nm) was quadratically proportional to the 
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Figure 5.4 (a) Normalized measured pump (817nm) wave spectra as a function of power in SMF28; (b) Normalized 
measured Stokes (1064nm) wave spectra as a function of power in SMF28; (c) Normalized measured FWM (663nm) 
wave spectrum output from SMF28. 
In addition, we verified the FWM effect using our CARS microscopy. Instead of inserting the 1-meter 
SMF28 before the entrance of the CARS microscopy, we mounted it directly under the I 0 ? (NA = 0.25, 
Newport) objective and captured the backward FWM (or nonresonant CARS) images from the proximal end of 
the fiber. The Epi-CARS channel was used with a bandpass filter (hq660/40m-2p, Chroma Technology Corp). 
Powers of the pump and the Stokes at the proximal end of MMF were 200 mW and 100 mW, respectively. 
Figure 5.5 shows a brightfield image of the well-cleaved proximal end of a 1-meter SMF28 and five CARS 
images from the proximal end ofthe !-meter SMF28 at various conditions, such as pump plus Stokes, pump only, 
distal end suspending in air or immersing in water/oil, and well-cleaved or bad-cleaved distal end. We observed 
strong FWM signals emerging from the fiber core when the pump (817nm) and Stokes (1064nm) waves were 
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coupled simultaneously into the SMF28 as shown in Fig. 5.5 (b). The circular pattern of the FWM signals 
indicated the mode distribution in the core of the SMF28 was not uniform. No FWM signal was detected when 
only the pump wave (817nm) was coupled into the SMF28 as shown in Fig. 5.5 (c). There were weak FWM 
signals when the well-cleaved distal end of the SMF28 was immersed in water (Fig. 5.5 (d)) or oil (Fig. 5.5 (e)) or 
when the distal end was bad-cleaved/cut (Fig. 5.5 (f)). Collectively, these findings suggested that the FWM 
signals were mainly generated in the forward direction. 
Figure 5.5 (a) Brightfield image of the well-cleaved proximal end of a 1-meter long SMF28; CARS images from 
proximal end of the 1-meter SMF28 at (b) 817nm + 1064nm and well-cleaved distal end suspending in air; (c) 817nm 
only and well-cleaved distal end suspending in air; (d) 817nm + 1064nm and well-cleaved distal end immersing in 
water; (e) 817nm + 1064nm and well-cleaved distal end immersing in oil; (f) 817nm + 1064nm and bad-cleaved/bad-cut 
distal end suspending in air. 
Figures 5.6 (a) and (b) show the forward and Epi CARS images of 1 Ojlm PEB spin-coated on a glass slide 
using ps lasers delivered through a 1-meter SMF28. The CARS images were verified by the results of single 
pump wave taken at 2845cm- 1• In Figure 5.6 (b), the Epi-CARS image clearly showed the characteristic ring 
structure of PEBs due to the relative large size of PEBs compared to the small coherence length of Epi CARS 
signals. In terms of the CARS image quality, such as contrast and resolution, no clear difference was noticed 
between using free-space and using a 1-meter SMF28 for delivery of the laser. To further assess the performance 
of delivering ps lasers through the SMF28 fiber, we imaged two types of mouse tissues ex vivo. Figures 5.6 (c) 
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and (d) show the Epi CARS images of the mouse kidney and ear, respectively. There were no discernable 
degradations with regard to the image quality obtained through fiber delivery compared to free-space delivery 
(74). In addition, we tested the stability of this SMF28 fiber-delivered CARS system by characterizing 
fluctuations of the CARS signal while imaging PEBs. The fluctuations ofthe CARS signal are 1.5% and 4.6% for 
the short-term (i.e. one-hour) and the long-term (i.e. two-day), respectively. These results demonstrated that the 
SMF28 can be used to deliver ps lasers for CARS imaging, and a filter can be used to block the FWM signals 
generated in the fiber. 
Figure 5.6 CARS images were captured by CARS system with delivery of ps lasers through SMF28. Forward (a) and 
Epi (b) CARS images of 101Jm PES spin-coated on a glass slide, scale bar is 51Jm. Epi CARS images of (c) mouse 
kidney and (d) mouse ear, scale bar is 1 01Jm. 
5.3.2. Polarization-based Suppression of FWM using a Microscopy Setup 
To maintain the stability of SOPs of the polarized laser lights during their travel in fibers, we employed PMFs to 
deliver the laser lights. PMFs have been demonstrated as a good choice to maintain the SOP of linearly-polarized 
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lights launched into the fiber during their propagation, with little or no cross-coupling of optical power between 
the two orthogonal linear polarization modes (163, 167). We examined the orientation of the main axes ofPMFs 
both passively and actively. First, we visualized the well-cleaved input fiber end ofPMFs using a digital camera 
through coupling with a lOx objective to identify the position of the stress-inducing elements and visually 
adjusted the geometric orientation of main axes as shown in the inset of Figure 5.2 (a). Then, we used the 
calibrated polarimeter to measure the output SOPs of the lasers at the output end of PMFs to ensure that lasers 
were well coupled into the fast and slow axes of PMFs. Meanwhile, we measured the polarization extinction ratio 
(PER=-lOlogPm;JPma.n Pm;n and Pmax are minimum output power and maximum output power, respectively) of 
PMFs using a linear polarizer and a power meter at the output of PMFs. The PER were 21.17dB and 21.27dB 
when the pump wave coupled into the fast or slow axes respectively, while the PER were 22.66dB and 21.38dB 
when the Stokes wave coupled into the fast or slow axes, respectively. Figure 5.7 illustrated the polarization state 
paths (red star points connected by green curves) of the pump (817nm) and Stokes (1064nm) on the Poincare 
sphere traced at the output of 1-meter PMFs as the linear polarizer at the input ofPMFs was rotated through 180°. 
We noted that all points were nearly located on the surface of the sphere, which means the degree of polarization 
of lights output from PMFs was nearly 100% (171 ). It indicated that little or no depolarization effect occurring in 
PMFs. Great-circle paths to be traced out on the Poincare sphere were obtained by rotating the linear polarizer 
through 180? The paths intersect the equators (blue curves) twice on opposite sides of the sphere. Since equators 
represent linear polarizations, these paths indicated that there were two positions of the linear polarizer that led to 
linearly polarized lights emerging from PMFs. The intersections with equators occurred on opposite sides of the 
sphere further showed that these two linearly polarized lights were orthogonal to each other (172). In fact, they 
were linearly polarized lights along the fast and slow axes of PMFs. 
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Figure 5.7 Polarization state paths (red star points connected by green curves) of (a) 817nm and (b) 1 064nm on the 
Poincare sphere traced at the output of 1-meter PMFs as the linear polarizer at the input of PMFs was rotated. Blue 
curves indicated equators which represents linear polarizations. 
Measured results of normalized FWM signals in four different cases are shown Figure 5.8 (a). According to 
Figure 5.8 (a), we noted as expected that the intensity ofFWM signal was a function of the relative angle between 
the linear polarization orientation of the pump wave and that of the Stokes wave. All four curves resembled 
sinusoidal curves. The maximal FWM intensity was obtained when linear polarization orientations of the pump 
and Stokes are same, i.e., the relative angle is around 0°, 180° and 360°. The minimal FWM intensity was 
obtained when linear polarization orientations of the pump and Stokes are orthogonal, i.e., the relative angle is 
around 90° and 270°. Therefore, FWM signals can be effectively suppressed by controlling the relative angle 
between the linear polarization orientations of the pump and Stokes waves. To obtain the minimal FWM signals, 
the relative angle should be set at 90°, i.e., the pump and Stokes waves propagates along fast and slow axes of 
PMF respectively or vice versa. Figure 5.8 (b) shows measured spectra of FWM signal peaks when the pump 
(817nm) and Stokes (1064nm) waves propagated in either the fast or slow axis of 1-meter PMFs. We noted that 
when the pump and Stokes waves were input at the slow and fast axis respectively, FWM intensity was 
suppressed by - 99% compared to the FWM intensity when the pump and Stokes waves were both input at the fast 
axis. There was no big difference in terms of performance of FWM suppression when the pump and Stokes waves 
coupled into either combination of orthogonal axes (i.e. 817nm at fast and 1 064nm at slow, or 817nm at slow and 
1064nm at fast), suggesting that we can employ either combination to suppress FWM in our system. 
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Figure 5.8 (a) Optical intensity of FWM signals emitted at 661.33nm as a function of the relative angle between the 
linear polarization orientation of the pump (817nm) and that of the Stokes (1064nm) coupled into 1-meter PMFs 
measured by an Oceanoptics HR4000 optical spectrometer; (b) Measured spectra of FWM signal peaks when the 
pump (817nm) and Stokes (1 064nm) propagated in either the fast or slow axis of 1-meter PMFs. 
For microscopy imaging of PEBs, in our first experiment, the linearly polarized pump and Stokes waves were 
both coupled into the fast axis of !-meter PMFs. At this point, the FWM intensity was about 8550 counts (blue 
peak in Figure 5.9 (b)). We captured CARS images of PEBs with and without placing the dual-wavelength 
waveplate into the PMF-delivered CARS microscopy system. The results were showed in Figure 5.9. Figure 5.9 
(a) and (b) illustrate forward and Epi CARS images of PEBs respectively when the dual-wavelength waveplate 
was not placed into the CARS system. Figure 6c and 6d show forward and Epi CARS images of PEBs 
respectively when the dual-wavelength waveplate was being placed into the CARS system. We noted that clear 
CARS images of PEBs (Fig. 5.9 (a) and (b)) were achieved when the dual-wavelength waveplate was not placed 
into the CARS system. It was because the pump and Stokes waves possessed identical SOP after emerging from 
the fast axis of PMFs such that they could produce strong CARS signals and clear CARS images using the 
microscope. However, only weak PEBs CARS images (Fig. 5.9 (c) and (d)) were obtained when the dual-
wavelength waveplate was placed into the system. It was because the pump and Stokes waves possessed identical 
SOP after emerging from the fast axis of PMFs. Once passed through the waveplate, their SOPs were thus 
changed to be orthogonal to each other. At this point, CARS signal was proportional to depolarization ratio of the 
Raman line [30-32]. Since the symmetric CH2 stretching vibration of PEBs was probed in our case and its 
depolarization ratio is typically quite small [32], only weak CARS signals were obtained when orthogonally 
polarized pump and Stokes waves excited PEBs. Another reason for the weak CARS signals in Fig.6c and 6d or 
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weak background in Fig.6 may be because the control voltage and gain of PMT might be set low when capturing 
CARS images. In experiments for Figure 5.9 and Figure 5.1 0, we kept all parameters of PMT constant when 
capturing CARS images regardless of orthogonality of polarized pump and Stokes waves. Since CARS signals of 
PEBs were very strong (e.g. in Fig.5.9 (a) and (b)) when pump and Stokes waves excited PEBs at identical SOP, 
to avoid over-saturation in this scenario, we might set the control voltage and gain ofPMT a little low. 
Figure 5.9 CARS images of 1 OJ.Im PEBs captured by 1-meter PMF-delivered CARS microscopy system. The linearly 
polarized pump and Stokes waves were both coupled into the fast axis of PMFs. Forward (a) and Epi (b) CARS images 
of PEBs when the dual-wavelength waveplate was not placed into the CARS system; forward (c) and Epi (d) CARS 
images of PEBs when the dual-wavelength waveplate was placed into the CARS system. Scale bar is 10j.lm. 
In our second experiment, the linearly polarized pump and Stokes waves were coupled into the slow and fast 
axis of PMFs, respectively, where the FWM intensity was about 97 counts (green peak in Figure 5.8 (b)). 
Compared to the results when the pump and Stokes waves were both coupled into the fast axis (i.e. case of Figure 
5.9), the FWM intensity was suppressed by ~99%. We captured CARS images of PEBs with and without placing 
the DWW into the PMF-delivered CARS microscopy system. The results are showed in Figure 5.10. Figure 5.10 
(a) and (b) are forward and Epi CARS images of PEBs when the DWW was not placed into the CARS system. 
Figure 5.10 (c) and (d), on the other hand, are forward and Epi CARS images of PEBs when the DWW was 
placed into the CARS system. We noted that only weak CARS images of PEBs (Fig. 5.10 (a) and (b)) were 
observed when the DWW was not placed into the CARS system. It resulted from the fact that the pump and 
91 
Stokes waves possessed orthogonal SOPs after emerging from the slow and fast axis ofPMFs. At this point, only 
weak CARS signals of PEBs could be obtained for aforementioned reason. Another reason for the weak CARS 
signals in Figure 5.10 (a) and (b) or weak background in Figure 5.10 may be because the control voltage and gain 
of PMT might be set low to avoid over-saturation when capturing CARS images. However, clear CARS images 
ofPEBs (Fig. 5.10 (c) and (d)) were obtained when the DWW was placed into the CARS system. It was due to 
the fact that SOPs of the pump and Stokes waves were changed back to identical polarization states after passing 
through the waveplate, resulting in strong CARS signals and clear CARS images of PEBs. Collectively, the two 
experiments above demonstrated that the DWW can be used to achieve conversion between identical and 
orthogonal SOPs of the pump and Stokes waves. 
(a) (b) 
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Figure 5.10 CARS images of 101Jm PEBs were captured by 1-meter PMF-delivered CARS microscopy system. The 
linearly polarized pump and Stokes waves were coupled into the slow and fast axis of PMFs respectively. Forward (a) 
and Epi (b) CARS images of PEBs when the dual-wavelength waveplate was not placed into the CARS system; forward 
(c) and Epi (d) CARS images of PEBs when the dual-wavelength waveplate was placed into the CARS system. Scale 
bar is 101Jm. 
Figure 5.11 shows Epi CARS images of mouse skin and liver tissues. We can clearly observe the cellular 
structure of the tissues. These results demonstrated that this CARS microscopy system can be used to image 
tissues accompanied with dramatically reduced FWM background noises generated in the fiber. 
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5.3.3. 
Figure 5.11 Epi CARS images of the mouse skin and liver tissues. Scale bar is 101-1m. 
Test of the Polarization-based FWM Suppression Strategy using a MMF-based CARS 
Microendoscopy Prototype Imaging System 
Figure 5. 12 shows the polarization state paths (red star points) of the pump and Stokes beams on the Poincare 
sphere traced at the output of !-meter SMF2g as the linear polarizer at the input was rotated through 1goo. We 
noted that the paths intersected the equators (blue curves) twice on the opposite sides of the sphere. Since equators 
represent linear SOPs, it indicated there were two positions of the input polarizer which led to linearly polarized 
output lights. The intersections with equators occurred on opposite sides of the sphere further showed that these 
two output lights were orthogonal [g] . Meanwhile, we recorded the two positions of the linear polarizer at inputs. 
They are g2o and 172° for the pump, and goo and 170° for the Stokes. Hence, we can use either the pump at g2o 
and Stokes at 170° or the pump at 172° and Stokes at goo for orthogonal SOPs of input pump and Stokes beams in 
fibers. The 2-degree deviation may be due to experimental errors. We used the pump at g2o and Stokes at 170° in 
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Figure 5.12 (Color online) Polarization state paths (red star points) of (a) 817nm and (b) 1064nm on the Poincare 
sphere traced at output of 1-meter SMF28 as the linear polarizer at input of SMF28 was rotated. Equators represent 
linear polarizations. 
Figure 5.13 shows measured FWM spectra as a function ofthe relative angle between the linear polarization 
orientation of the pump (1OOm W) and that of the Stokes (1OOm W), and the inset in Fig. 3 were corresponding 
intensity variations at FWM peak of 661.3nm. It suggested that the FWM intensities can be effectively suppressed 
by controlling the relative angle between the linear polarization orientations of the pump and Stokes beams. The 
minimal FWM was obtained at 90°, i.e. SOPs of two beams were orthogonal. 
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Figure 5.13 (Color online) FWM spectra as a function of the relative angle between the linear polarization orientation of 
the pump and that of the Stokes, inset was the corresponding intensity variation at FWM peak of 661 .3nm from 0° to 
180°. 
For imaging of PEBs under three different polarization configurations, we obtained very strong signals in 
case I (Fig. 5.14 (a)), very weak signals in case 2 (Fig. 5.14 (b)) and strong signals in case 3 (Fig. 5.14 (c)). 
Figure 5.14 (d) showed the intensity profiles along vertical green lines in figures 5.14 (a)-( c). Due to polarization 
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effect, we believed that case I produced both very strong CARS and very strong FWM signals from samples and 
fibers respectively, while case 2 produced very weak CARS (proportional to depolarization ratio) and very weak 
FWM signals [IO, 7], and case 3 produced strong CARS and very weak FWM signals [8]. Compared to case I, 
the decrease of intensity in case 3 was caused by the suppression of FWM signals and the insertion loss of the 
DWW. In our experiments, we found that at the PMT, Epi FWM signals scattered back by samples were much 
weaker than Epi CARS signals even in case I. When lasers were tuned to an off-resonance frequency of PEBs 
(e.g. 3I00cm-1) or when PEBs were illuminated by the FWM beam only, with the pump and Stokes beams filtered 
out, we obtained weak FWM signals with nearly blank FWM scattering images. We believe this may be caused 
by the much lower collection efficiency and larger loss of FWM signals compared to those of CARS signals in 
our current system due to the incoherent property of scattered Epi FWM signals, relatively large setup, and 
unoptimized optics. We believe this FWM effect would be intensely prominent in a miniaturized (e.g. mm-sized) 
system. In addition, we captured the excitation spectrum of PEBs (Fig.4e ), which indicated that images in Figure 
5.I4 were Epi CARS images. The donut shape structure of the PEB was highlighted by a red dashed circle in 
Figure 5.14 (a) and (c). We believe the effects that many PEBs did not show a donut shape and appeared smaller 
than their real sizes may be due to the PEB sample issue (i.e. sometimes we do not observe the donut shape in dry 
PEB samples), hardware limitations and the out-of-focus effect. Figures 5.I4 (f) shows a CARS image of the 
mouse skin under the condition of case 3. These results showed that in this microendoscopy prototype system: (i) 
the DWW can be used to achieve the conversion between identical and orthogonal SOPs of excitation beams; (ii) 
this polarization-based FWM-suppressing scheme can reduce FWM signals; (iii) SMF28s can be used in this 
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Figure 5.14 (Color online) CARS images of 10J,Jm PEBs. (a) parallel-polarized pump and Stokes beams without the DWIN 
insertion; (b) orthogonal-polarized pump and Stokes without the DWIN insertion; and (c) orthogonal-polarized pump and 
Stokes with the DWIN insertion; (d) intensity profiles along vertical green lines in fig .(a)-(c) ; (e) CARS spectrum of PEBs at 
pump (800nm-826nm) and Stokes (1064nm); (f) mouse skin tissue. Scale bar is 10J,Jm. 
5.4. Conclusion 
This chapter aims to develop a feasible strategy of using optical fibers to deliver excitation lasers for CARS 
imaging. This is an essential step of miniaturizing current benchtop microscopy CARS setup to a size that is 
compatible with intraoperative interventions. We started by identifying a FWM background signal, caused by 
simultaneous transmission of the two excitation lasers inside the fiber. This background, if not removed, will 
significantly reduce the signal quality for imaging purpose given the fact that the generated background is at the 
same wavelength as the desired CARS emission. Although a long-pass filter can be used to remove this 
background in a microscopy system, the FWM noise remains a prominent problem for developing an endoscope 
system where such filtering is not feasible . Leveraging on the fact that the intensity of FWM signals highly 
depends on the relative SOPs between the pump and Stokes waves, we developed a polarization-based 
suppression strategy. Best suppression is achieved when SOPs of the pump and Stokes waves are orthogonal to 
each other. A DWW was used to change the orthogonality of the two excitation waves and realign their SOPs 
back to identical for high-efficiency CARS imaging. The proposed strategy was tested on both a microscope setup 
and a prototype endoscope setup. ln the later, the same fiber was used for delivery of excitation lasers and 
collection of generated CARS signals, a scenario very much alike to that during an in vivo application. Our results 
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showed that this polarization-based FWM-suppressing scheme can dramatically reduce FWM signals in both 
setups, while good image quality is achievable during followed CARS imaging applications. 
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6. Conclusions and Future Directions 
6.1. Introduction 
Optical imaging technologies are offering revolutionary changes aimed at improving health care and advancing 
biomedical research. Bypassing the lengthy FDA approval process commonly required for label-based approaches 
using exogenous dyes, label-free methods provide a facilitated route for building novel imaging instrumentation 
for human disease diagnosis and treatment. However, two common problems can impede the development of such 
label-free imaging devices for clinical use. First, for clinical diagnosis, an effective imaging and analytical 
platform should be developed for accurate evaluation of imaging data. Second, the imaging system needs to be 
miniaturized to a size compatible with clinical intervention. The first problem was addressed in Chapters 2 to 4 of 
this thesis by offering a computerized pattern recognition and classification strategy. As the major contribution of 
this thesis, the strategy is based on extraction and calibration of a series of pathologically related features for 
disease diagnosis, thus providing meaningful diagnostic information with reproducible results. By doing so, the 
CARS technique has been bridged to clinical cancer diagnosis and thus holds substantial translational potentials. 
Meanwhile, as a project I contributed, a raster-scan CARS microendoscope prototype was constructed in Chapter 
5, as a proof-of-concept strategy for miniaturization ofthe CARS system. Specifically, using a polarization-based 
scheme in the optical fiber for delivery of both excitation lasers and reflected CARS signals, the FWM 
background signal was identified and suppressed. This innovation advances the development of a real all-fiber-
based imaging probe that can be further incorporated with the diagnostic platform for future intraoperative 
imaging of cancer tissues. 
6.2. Diagnose Different Cancer and Nerve Structures using Disease-related Features 
The ideal imaging system used for disease diagnosis must accurately define the imaged regions. To reach a high 
level of accuracy and specificity, dyes and molecular contrast agents, such as DAPI, are commonly used to 
highlight certain types of cells or certain cellular components. While CARS, as a label-free technique, eliminates 
the need for contrast agents, it still suffers a lower level of image contrast and specificity than dye-based 
techniques. As a result, an interpretation platform is required to afford diagnostic utility to the imaged features. 
Such a platform requires image segmentation, feature extraction and disease classification components. As such, 
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our first aim focused on determining the targeted objects that need to be segmented and calibrated from a CARS 
image. Currently,in order to accurately identify lesion typology for definitive treatment, pathologists routinely 
stain tissue sections taken from biopsy/excision to examine changes in such cellular and histologic features as cell 
size, cell-cell distance, and formation of fibrous structures (114). However, this method is subject to inter-
observer variations, while the CARS technique already provides high-resolution images which can clearly detect 
these features and do so without tissue staining with exogenous agents. Therefore, we hypothesized the 
development of a pattern recognition method whereby such images could be used as a basis for the quantitative 
classification of these cellular features in a way that would ~ead to effective analysis of tissue samples. 
In Chapter 2, this hypothesis was initially tested on prostate cancer, where the boundaries of the prostate 
and affiliated nerve structures need to be correctly identified. Accordingly, we have used CARS to identify the 
unique boundaries of prostate glands and CNs, using their distinctive cellular features. Particularly, one of the 
cellular parameters, average cell neighbor distance, was determined to be a good candidate for cancer 
differentiation using PCA. Inspired by these research findings, our cellular feature-based platform was further 
tested on lung cancer and breast cancer, where definitive detection and differentiation of cancers are needed for 
early cancer detection or intraoperative margin evaluation. In-depth classification analysis was performed in these 
applications, showing high accuracies and specificities for both diseases. To the best of our knowledge, this is the 
first label-free and knowledge-based diagnostic platform to quantitatively identify cancer and nerve structures. 
6.3. Development of a Prototype Microendoscope for CARS imaging using a Polarization-
based FWM Suppression Strategy 
As noted above, the development of a computerized pattern recognition system has strengthened the ability of 
CARS to identify cellular structures by quantitatively calibrating pathologically related features for diagnostic 
evaluation. Thus, the combination of CARS with this software program provides an unparalleled opportunity to 
translate this strategy into real-time clinical applications. The next rational step focuses on developing a feasible 
strategy for the miniaturization of the current benchtop setup to a size that is compatible with intraoperative 
interventions. 
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An essential component of such a system is an optical fiber, which functions to deliver the laser light, 
while, at the same time, collecting the reflected CARS signal. We started by identifying a FWM background 
signal in the optical fiber, which was caused by simultaneous transmission of the two excitation lasers. This type 
of background significantly reduces the signal quality for imaging purposes because it overlays the CARS 
emission wavelength. A long-pass filter is normally used to block this background in a microscopy setup. 
However, such a strategy is not feasible for an endoscope system where detection is usually made at the back end 
of the fiber based on size considerations. 
However, since we know that FWM signals depend on the relative SOPs between the two excitation 
beams, a polarization-based suppression approach was developed, and the best suppression was achieved when 
SOPs of the pump and Stokes waves were orthogonal to each other. Therefore, a DWW was used to change the 
orthogonality of the two excitation waves and realign their SOPs back to identical for high-efficiency CARS 
imaging. The proposed strategy was tested on both a microscope setup and a prototype endoscope setup. Our 
results showed that this suppression mechanism could dramatically reduce FWM signals generated in PMFs up to 
approximately 99% with a microscopy setup. Moreover, because this polarization-based mechanism only changes 
SOP of light, it will not block the returned emission signals in the delivery fiber for detection in most endoscopy 
designs. Finally, we tested this scheme on an endoscope setup and obtained high-resolution CARS images. 
Therefore, the results in Chapter 5 demonstrate the feasibility of developing a fiber microendoscope 
system for intraoperative CARS imaging. Combined with the previously described morphology-based pattern 
recognition platform, this thesis demonstrates the translational value of this imaging technique. 
6.4. Future Directions 
Although cellular features were extracted and utilized to develop a diagnostic platform in this study, only 2-D 
data were used. However, as a multiphoton imaging technique, CARS already provides optical sectioning 
capability, enabling 3-D imaging with an axial resolution of about 1 11m. Therefore, a stack of images can be 
taken from the same field of view, but with different imaging planes, generally up to a couple hundreds of 
micrometers in depth. These images can be reconstructed in 3-D through interpolation between different planes. 
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Under these circumstances, the current 2-D segmentation system could be modified to perform nuclear 
segmentation on the reconstructed 3-D data and make calibrations of cellular structures. As such, several features 
can be more accurately measured. For example, cell-cell distance will be measured as the 3-D distance between 
individual cells, and cell size will be replaced by cell volume. These 3-D features are likely to be much closer to 
the actual tissue structures and can thus potentially improve some of the classification accuracies, such as 
separating lung adenocarcinoma from squamous cell carcinoma. 
While a fiber-delivery strategy has been demonstrated in Chapter 5, current image quality acquired from 
the prototype endoscope system was significantly worse than that from the microscopy setup. This was mainly 
caused by the restricted spatial resolution of the transition stage used in this study, as well as the limitations of the 
in-house software system developed to control both stage movement and image acquisition. The use of chromatic 
aberration corrected miniature optics and laser scanning schemes (e.g., microelectromechanical systems (MEMS)-
based scanning micro-mirrors) could improve the image quality in future endoscope setups. Still, compared to the 
microscopy system, potentially worse imaging resolutions in the fiber-based system are always expected. They 
may prevent accurate identification of cell nuclear structures and, in turn, complicate interpretation of disease 
status using current pattern recognition software. To address this problem, minimum manual interventions, such 
as selection of cell centers, might be required to improve the segmentation efficacy and accuracy. Meanwhile, 
additional imaging features (e.g., wavelet features, Haralick texture features, and zernike moment features) could 
even be extracted from the images without nuclear segmentation for training and testing of the classification 
system, which functions to the same end for identification of different tissue structures. 
As introduced in Chapter 4, multi complex CARS has been already studied for determination of tumor 
boundaries using a breast cancer rat model (67). In that study, a border source laser was used to generate a 
spectrum of CARS emission, a spectrum determined by the chemical composition of the specimen, thus enabling 
use of the chemical specificity feature of the CARS technique. Different from that approach, the study in this 
thesis focuses on extracting morphological information from CARS images acquired at a single vibrational 
frequency. However, the two approaches are not mutually exclusive and could be combined in future studies, 
allowing the use of spectral information with morphology data for increased accuracy and specificity. In addition, 
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CARS can be combined with other imaging modalities to provide extended imaging depth to overcome current 
limitations of a couple of hundreds micrometers. For example, a recent study showed the use of vibrational 
photoacoustic (VPA) microscopy with millimeter-scale penetration depth (173). In this study, optical excitation of 
molecular overtone vibration; a technique similar to CARS, was combined with photoacoustic imaging. As a 
result, the imaging depth was effectively extended to millimeter scale, while chemical specificity and micrometer-
level spatial resolutions were also achieved. Finally, the developed CARS microendoscope can be further 
combined with image--guided intervention, in which the CARS probe can be located and guided by another 
imaging modality, like CT or MRI. By doing so, the advantages of medical imaging and optical imaging 
techniques can be combined to provide millimeter or centimeter level resolutions in tracking and guiding the 
probe, while sub-micrometer level resolution in performing diagnostic evaluations. 
This thesis represents a significant advancement for in vivo label-free imaging and diagnosis of different 
cancers, enabling early detection of disease lesions as well as intraoperative evaluation of margin status. We 
anticipate that the CARS-based imaging approach will allow real-time assessment of region of interest, thus 
improving patient care and treatment outcomes. 
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